1(866) 923-2423

Call today for a free color catalog.
Our friendly customer care specialists are waiting for your call.

 Diabetes News
Some Insulin Production Found In Long-Term Type 1 Diabetes
  • Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. The study results appear in the March issue of Diabetes Care...
  2012-02-22
Researchers Track Diabetes' First Steps As Disease Emerges
  • Scientists have taken a remarkably detailed look at the initial steps that occur in the body when type 1 diabetes mellitus first develops in a child or young adult. The analysis comes from a team of researchers and physicians at the University of Rochester Medical Center who have expertise both in the laboratory and in treating patients...
  2012-02-20
Research Suggests That Diabetes May Start In The Intestines
  • Scientists at Washington University School of Medicine in St. Louis have made a surprising discovery about the origin of diabetes. Their research suggests that problems controlling blood sugar - the hallmark of diabetes - may begin in the intestines. The new study, in mice, may upend long-held theories about the causes of the disease...
  2012-02-17
Protein May Play Role In Obesity, Diabetes, Aging
  • Researchers at Washington University School of Medicine in St. Louis have identified a potent regulator of sensitivity to insulin, the hormone that controls blood sugar levels. The new findings may help scientists find better treatments for type 2 diabetes, obesity and other health problems caused by the body's inability to properly regulate blood sugar...
  2012-02-17
Screening For Diabetes Using Blood From Periodontal Disease
  • Oral blood samples drawn from deep pockets of periodontal inflammation can be used to measure hemoglobin A1c, an important gauge of a patient's diabetes status, an NYU nursing-dental research team has found. Hemoglobin A1c blood glucose measures from oral blood compare well to those from finger-stick blood, the researchers say...
  2012-02-15
In Young Sri Lankans Diabetes Risk Factors Much Higher Than Previously Thought
  • Scientists at King's College London and the National Diabetes Centre (Sri Lanka) have found evidence of a high number of risk factors for type 2 diabetes among the young urban population in Sri Lanka...
  2012-02-15
The Greatest Mortality Risk For Diabetics Is Diabetic Cardiomyopathy
  • Millions of people suffer from type 2 diabetes. The leading cause of death in these patients is heart disease. Joseph Hill and colleagues, at the University of Texas Southwestern Medical Center, Dallas, have now identified, through their work in mice, a potential new therapeutic approach to reduce the prevalence of heart failure and improve the long-term survival of patients with type 2 diabetes...
  2012-02-14
Hypoglycemia Reduced By Automatic Suspension Of Insulin Delivery Via Insulin Pumps
  • An automated on/off feature built into insulin pump systems can suspend insulin delivery when it detects low blood glucose levels (via continuous glucose monitoring), significantly reducing the severity and duration of hypoglycemia in individuals with type 1 diabetes, according to a study published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc...
  2012-02-13
Largest-Ever Gene Study Of Type 2 Diabetes Finds Variants Across Many Ethnic Groups
  • The largest genetics study to date of type 2 diabetes (T2D) has identified new gene variants associated with risk for the common metabolic disease. An international scientific consortium, studying multiethnic populations, uncovered genes that may point to biological targets for developing more effective drugs for T2D...
  2012-02-13
Specific Goals In Nutrition Needed To Improve Diabetes Diet
  • A specific goal to eat a set number of daily servings of low-glycemic-index foods can improve dietary habits of people with Type 2 diabetes, according to new research...
  2012-02-12
The 'ROCK'y Road To Diabetic Kidney Failure
  • A protein kinase known as ROCK1 can exacerbate an important process called fission in the mitochondria, the power plants of cells, leading to diabetic kidney disease, said researchers from Baylor College of Medicine in a report that appears online in the journal Cell Metabolism. (ROCK1 stands for (Rho-associated coiled-coil containing protein kinase 1...
  2012-02-09
Researchers Pave The Way For Improving Treatment For Type 2 Diabetes
  • In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body...
  2012-02-09
Based On CE Analysis Of Oral Medications, ACP Recommends Metformin To Treat Type 2 Diabetes
  • The American College of Physicians (ACP) recommends that clinicians add metformin as the initial drug treatment for most patients with type 2 diabetes when lifestyle modifications such as diet, exercise, and weight loss have failed to adequately improve high blood sugar...
  2012-02-07
News From The Annals Of Internal Medicine: Feb. 7 2012
  • 1...
  2012-02-07
Taste Receptors Discovered In Pancreatic Beta Cells Can Sense Fructose And Stimulate Insulin Secretion
  • Taste receptors on the tongue help us distinguish between safe food and food that's spoiled or toxic. But taste receptors are now being found in other organs, too...
  2012-02-07
One In Ten Cases Of Diabetes Goes Untreated
  • Rates of diabetes vary widely across developing countries worldwide, according to a new analysis led by Dr. Longjian Liu of Drexel University's School of Public Health. Worldwide, four in five people with diabetes now live in developing countries...
  2012-02-07
Probable Mechanism Underlying Resveratrol Activity Revealed By NIH Study
  • National Institutes of Health researchers and their colleagues have identified how resveratrol, a naturally occurring chemical found in red wine and other plant products, may confer its health benefits. The authors present evidence that resveratrol does not directly activate sirtuin 1, a protein associated with aging...
  2012-02-05
Exercise In Low Oxygen Environment May Result In Improved Insulin Sensitivity
  • Intermittent exercise with and without low oxygen concentrations (or hypoxia) can improve insulin sensitivity in type 2 diabetics, however exercise while under hypoxic conditions provides greater improvements in glycemic control than intermittent exercise alone, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM)...
  2012-02-05
Link Between Insulin Resistance And Brain Health In Elderly
  • New research from Uppsala University shows that reduced insulin sensitivity is linked to smaller brain size and deteriorated language skills in seniors. The findings are now published in the scientific journal Diabetes Care. The main hormonal function of insulin is to support the uptake and use of glucose in muscles and fat tissues...
  2012-02-03
Seasonal Changes May Influence The Efficacy Of Vaccination Against Diabetes
  • The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase 3 trials that failed to show significant effects. One possible explanation may be seasonal variations in the immune system, claim those responsible for the study that was published in the New England Journal of Medicine (NEJM)...
  2012-02-03
Brain Energy Metabolism Improved By Decaffeinated Coffee
  • Researchers from Mount Sinai School of Medicine have discovered that decaffeinated coffee may improve brain energy metabolism associated with type 2 diabetes. This brain dysfunction is a known risk factor for dementia and other neurodegenerative disorders like Alzheimer's disease. The research is published online in Nutritional Neuroscience...
  2012-02-02
Biological Time-Keeper Linked To Diabetes
  • Researchers in Lille and Paris demonstrated that mutations in the melatonin receptor gene (melatonin or the "hormone of darkness" induces sleep) lead to an almost sevenfold increase in the risk of developing diabetes. This research, which was published in Nature Genetics on 29 January 2012, could contributed to the development of new drugs for the treatment or prevention of this metabolic disease...
  2012-02-01
New Genetic Study Links Body Clock Receptor To Diabetes
  • A study published in Nature Genetics has found new evidence for a link between the body clock hormone melatonin and type 2 diabetes. The study found that people who carry rare genetic mutations in the receptor for melatonin have a much higher risk of type 2 diabetes...
  2012-01-30
Study Finds Mysterious Protein's Entwined Arm Movements May Control Fate Of Potentially Toxic Payload
  • Like a magician employing sleight of hand, the protein mitoNEET - a mysterious but important player in diabetes, cancer and aging - draws the eye with a flurry of movement in one location while the subtle, more crucial action takes place somewhere else...
  2012-01-30
Amylin's Once-Weekly Diabetes Injection Finally Wins FDA Approval
  • On Friday, the US Food and Drug Administration finally approved Amylin Pharmaceutical's diabetes drug Bydureon, which provides glycemic control for diabetes type 2 in a once-weekly injection. The approval follows two earlier rejections in 2010, when the FDA asked the company to go back and carry out a new trial of the drug's effect on heart rhythm...
  2012-01-29
Amylin's Once-Weekly Diabetes Injection Finally Wins FDA Approval
  • On Friday, the US Food and Drug Administration finally approved Amylin Pharmaceutical's diabetes drug Bydureon, which provides glycemic control for diabetes type 2 in a once-weekly injection. The approval follows two earlier rejections in 2010, when the FDA asked the company to go back and carry out a new trial of the drug's effect on heart rhythm...
  2012-01-28
Lower Limb Amputation Rates Associated With Diabetes Drop, US
  • An investigation by the Centers for Disease Control and Prevention, found that between 1996 and 2008, the number of leg and foot amputations among U.S. individuals, aged 40+ with diagnosed diabetes, decreased by 65%. The study, entitled "Declining Rates of Hospitalization for Non-traumatic Lower-Extremity Amputation in the Diabetic Population Aged 40 years or Older: U.S...
  2012-01-27
Large Drop In Leg And Foot Amputations Among Adult Diabetics, CDC
  • There has been a large drop in the rate of leg and foot amputations among Americans aged 40 and over with diagnosed diabetes, according to a new study by the US Centers for Disease Control and Prevention (CDC) published in the February issue of Diabetes Care. The study reports that between 1996 and 2008 the rate of such amputations fell by 65%...
  2012-01-26
Patients With Diabetes Benefit From Lifestyle Counseling In Primary Care Setting
  • Lifestyle counseling, practiced as part of routine care for people with diabetes, helps people more quickly lower blood glucose, blood pressure and cholesterol levels and keep them under control, according to a large, long-term study published in the February issue of Diabetes Care...
  2012-01-26
Nurturing Mothers Rear Physically Healthier Adults
  • Nurturing mothers have garnered accolades for rescuing skinned knees on the playground and coaxing their children to sleep with lullabies. Now they're gaining merit for their offspring's physical health in middle age...
  2012-01-25
Saliva Test Could Replace Blood Test For Diabetics
  • Engineers at Brown University have designed a biological device that can measure glucose concentrations in human saliva. The technique could eliminate the need for diabetics to draw blood to check their glucose levels. The biochip uses plasmonic interferometers and could be used to measure a range of biological and environmental substances. Results are published in Nano Letters...
  2012-01-25
Cellular Degradation May Determine The Health Benefits Of Exercise
  • The health benefits of exercise on blood sugar metabolism may come from the body's ability to devour itself, UT Southwestern Medical Center researchers report in the journal Nature. Autophagy is a process by which a cell responds to starvation and other stresses by degrading damaged or unneeded parts of itself to produce energy. It is sometimes called the cell's housekeeping pathway...
  2012-01-24
News From The Journals Of The American Society For Microbiology
  • Saturated Fatty Acids Lead to Mitochondrial Dysfunction and Insulin Resistance Excessive levels of certain saturated fatty acids cause mitochondria to fragment, leading to insulin resistance in skeletal muscle, a precursor of type 2 diabetes, according to a paper in the January issue of the journal Molecular and Cellular Biology...
  2012-01-23
TNF Receptor Levels In The Blood Warn Of Kidney Problems For Individuals With Type 1 And Type 2 Diabetes
  • Levels of certain blood proteins indicate which diabetes patients will likely develop life-threatening kidney problems in the future, according to two studies appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results could help physicians protect the kidney health of patients with diabetes years before any visible signs of trouble arise...
  2012-01-21
New Light Shed On Link Between 'Killer Cells' And Diabetes
  • Killer T-cells in the human body which help protect us from disease can inadvertently destroy cells that produce insulin, new research has uncovered. The study provides the first evidence of this mechanism in action and could offer new understanding of the cause of Type 1 diabetes...
  2012-01-17
"Smart" Nanotherapeutics Developed That Deliver Drugs Directly To Pancreas
  • A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas...
  2012-01-16
Researchers Identify Pivotal Immune Cell In Type 1 Diabetes In Humans
  • Researchers at the La Jolla Institute for Allergy & Immunology have proven - for the first time in human tissues - the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas...
  2012-01-15
Scientists Isolate Hormone That Triggers Health Benefits Of Exercise
  • An international team of scientists has isolated a natural hormone or chemical messenger in muscle cells that triggers some of the important health benefits of exercise. They have named it "irisin", after the Greek messenger goddess, and believe it is a promising candidate for developing drugs to treat diabetes, obesity and maybe even cancer...
  2012-01-14
Coffee Drinkers At Reduced Risk Of Type 2 Diabetes
  • Why do heavy coffee drinkers have a lower risk of developing Type 2 diabetes, a disease on the increase around the world that can lead to serious health problems? Scientists are offering a new solution to that long-standing mystery in a report in ACS' Journal of Agricultural & Food Chemistry...
  2012-01-13
Protein Linking Exercise To Health Benefits Isolated By Researchers
  • A team led by researchers at Dana-Farber Cancer Institute has isolated a natural hormone from muscle cells that triggers some of the key health benefits of exercise. They say the protein, which serves as a chemical messenger, is a highly promising candidate for development as a novel treatment for diabetes, obesity and perhaps other disorders, including cancer...
  2012-01-13
Discovery Of Dance Between Protein And Binding Partners Could Influence Design Of Future Diabetes Treatments
  • Using a blend of technologies, scientists from the Florida campus of The Scripps Research Institute have painted a new picture of how biochemical information can be transmitted through the modification of a protein. Previously, scientists believed that during the pairing of proteins and their binding partners ("ligands"), proteins modified their shape while ligands remained stable...
  2012-01-12
Spotlight On Lifestyle Interventions For Diabetes
  • An Emory University study* published in the January issue of Health Affairs assesses real-world lifestyle interventions to help delay or prevent the costly chronic disease that affects nearly 26 million Americans...
  2012-01-12
Type 1 Diabetes Reversed With Stem Cells From Cord Blood
  • Stem cells from cord blood "re-educated" the immune system T cells of people with type 1 diabetes so their pancreas started producing insulin again, thereby reducing the amount of insulin they needed to inject. These are the findings of a study led by Dr Yong Zhao, from University of Illinois at Chicago that were published online on Tuesday in the open access journal BMC Medicine...
  2012-01-11
Atherosclerotic Lesions In Diabetic Patients May Be Repaired By Insulin Therapy
  • New research reveals that insulin applied in therapeutic doses selectively stimulates the formation of new elastic fibers in cultures of human aortic smooth muscle cells. These results advance the understanding of the molecular and cellular mechanisms of diabetic vascular disease. The study is published in the February issue of the American Journal of Pathology...
  2012-01-11
Treatment For Diabetes And Depression Improves Both
  • Patients simultaneously treated for both Type 2 diabetes and depression improve medication compliance and significantly improve blood sugar and depression levels compared to patients receiving usual care, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania...
  2012-01-11
Diabetes Type 1 Reversed By Stem Cell Therapy
  • Type 1 diabetes is caused by the body's own immune system attacking its pancreatic islet beta cells and requires daily injections of insulin to regulate the patient's blood glucose levels...
  2012-01-11
Personalized Medicine Holds Promise For Preventing And Treating Diabetes
  • With the trend in healthcare moving toward an era of personalized medicine, there is much anticipation and hope that customized approaches to prevention and treatment based on a person's genetic make-up will result in better health outcomes...
  2012-01-11
Patients Have Time To Learn Lifestyle Changes Following Diagnosis Of Diabetes, Hypertension, Before Drugs Become Necessary
  • A new study suggests that middle-aged adults recently diagnosed with diabetes and hypertension have time to try to learn how to control their high blood pressure without medications, but not too much time...
  2012-01-10
No Proven Added Benefit Of Linagliptin
  • Drug manufacturer deviates from appropriate comparator therapy specified by the G-BA Linagliptin (trade name: Trajenta®) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise...
  2012-01-10
Experts Suggest All Hospitalized Patients Have Blood Glucose Levels Tested
  • Hyperglycemia, or having high glucose levels in the blood, is a common, serious and costly health care problem in hospitalized patients...
  2012-01-09
Researchers Discover Protein That May Represent New Target For Treating Type 1 Diabetes
  • Researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine and colleagues have discovered a new protein that may play a critical role in how the human body regulates blood sugar levels. Reporting in the current issue of Pancreas, the research team says the protein may represent a new target for treating type 1 diabetes...
  2012-01-06
Scientists Reassess Weight Loss Surgery For Type 2 Diabetes
  • Weight loss surgery is not a cure for type 2 diabetes, but it can improve blood sugar control, according to a new study published in the British Journal of Surgery...
  2012-01-06
Scientists Reassess Weight Loss Surgery For Type 2 Diabetes
  • Weight loss surgery is not a cure for type 2 diabetes, but it can improve blood sugar control, according to a new study published in the British Journal of Surgery...
  2012-01-05
Explaining Link Between Heart Failure And Diabetes
  • Either heart failure or diabetes alone is bad enough, but oftentimes the two conditions seem to go together. Now, researchers reporting in the January Cell Metabolism appear to have found the culprit that leads from heart failure to diabetes and perhaps a novel way to break that metabolic vicious cycle...
  2012-01-05
Glucose-Induced Injury In Kidney Cells Reduced By Hydrogen Sulfide: Finding Lays Basis For Studies In Animal Models Of Diabetic Kidney Disease
  • Hydrogen sulfide, a gas notorious for its rotten-egg smell, may have redeeming qualities after all. It reduces high glucose-induced production of scarring proteins in kidney cells, researchers from The University of Texas Health Science Center San Antonio report in the Journal of Biological Chemistry. The paper is scheduled for print publication in early 2012...
  2012-01-05
Gestational Diabetes Linked To ADHD Risk In Offspring
  • According to a report Online First by Archives of Pediatrics & Adolescent Medicine, babies who are born to mothers with diabetes during their pregnancy and/or living in low income households, have a higher risk of subsequently developing ADHD during childhood...
  2012-01-04
Symphony Transdermal Continuous Glucose Monitoring Trial - Positive Results
  • Positive results were announced by Echo Therapeutics from its clinical investigation of its Symphony tCGM System in individuals with type 1 and type 2 diabetes. Echo is developing the system as a wireless, non-invasive, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery...
  2012-01-04
DNA Implanted Bacteria To Detect Glucose
  • Should a study by a team of students from Missouri University of Science and Technology become reality, individuals suffering with diabetes will be able to monitor their blood sugar levels in a more cost-effective way...
  2012-01-04
Young Diabetics Struggle To Get Good Night's Sleep, Health, Behavior Problems Ensue
  • New research finds that many young people with type 1 diabetes struggle to get a good night's sleep and this leads to increased health and behavior problems, such as poorer control of blood sugar and worsening of academic performance...
  2012-01-03
Student Team's Glucose Sensor Uses DNA Instead Of Chemicals
  • People with diabetes may one day have a less expensive resource for monitoring their blood glucose levels, if research by a group of Missouri University of Science and Technology students becomes reality...
  2011-12-29
Innovative Hebrew University Research Approach Successfully Maps Susceptibility To Type 2 Diabetes
  • Research carried out at the Hebrew University of Jerusalem has provided the first proof of molecular risk factors leading to type 2 diabetes, providing an "early warning" sign that could lead to new approaches to treating this and other human disease conditions...
  2011-12-29
Can Nerve Growth Factor Gene Therapy Prevent Diabetic Heart Disease?
  • Diabetes is a major risk factor for cardiovascular disease and can reduce blood supply to the heart tissue and damage cardiac cells, resulting in heart failure. New research has investigated if nerve growth factor (NGF) gene therapy can prevent diabetic heart failure and small vascular disease in mice...
  2011-12-23
Study Aims To Create Diabetes Food Box Model For Food Banks
  • Community food banks may soon be able to improve how the estimated millions of people living with Type 2 diabetes and food insecurity manage their disease. Researchers and community groups have come together to develop a model that ensures food banks can contribute to successful, long-term diabetes management...
  2011-12-22
Lilly And Amylin Mutually Agree To End Diabetes Alliance And Transition Exenatide Responsibility To Amylin
  • Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) ("Amylin") and Eli Lilly and Company (NYSE: LLY) ("Lilly") today announced an agreement to terminate their alliance for exenatide and resolve the outstanding litigation between the companies...
  2011-12-22
Novartis Announces Termination Of ALTITUDE Study With Rasilez®/ Tekturna® In High-Risk Patients With Diabetes And Renal Impairment
  • Novartis announced that following the seventh interim review of data from the ALTITUDE study with Rasilez®/Tekturna® (aliskiren), a decision to terminate the trial has been taken on the recommendation of the independent Data Monitoring Committee (DMC) overseeing the trial...
  2011-12-22
UMass Clinical Study Reduces Diabetes Risk Among Latinos
  • An inexpensive, culturally sensitive diabetes prevention program created by researchers at the University of Massachusetts Medical School reduced pre-diabetes indicators in a Latino population at risk for developing diabetes...
  2011-12-19
Patent Issued For Treatment Of Diabetes
  • Omni Bio Pharmaceutical, Inc. ("Omni Bio") (OTC OMBP.OB) announced that U.S. Patent No. 8,071,551, entitled "METHODS AND COMPOSITIONS FOR TREATING DIABETES," was issued by the United States Patent and Trademark Office on December 6, 2011 (the "Diabetes Patent"). The Diabetes Patent expires in May 2022...
  2011-12-18
Insulin Signaling Is Distorted In Pancreases Of Type 2 Diabetics
  • Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells - the cells that produce insulin. The finding is described in the journal PLoS ONE. Franco Folli, M.D., Ph.D., of the School of Medicine at The University of Texas Health Science Center San Antonio, and Rohit Kulkarni, M.D., Ph.D...
  2011-12-16
Blood Sugar Lowered By Brief, High-Intensity Workouts In Diabetics
  • Researchers at McMaster University have found that brief high intensity workouts, as little as six sessions over two weeks, rapidly lower blood sugar levels in type 2 diabetics, offering a potential fix for patients who struggle to meet exercise guidelines. The small proof-of-principle study, conducted on eight diabetics, appears in the latest edition of the Journal of Applied Physiology...
  2011-12-14
Clues To Development Of The Pancreas Provided By Rare Genetic Disorder Could Lead To Diabetes Therapy
  • A rare genetic disorder has given researchers at the University of Exeter a surprising insight into how the pancreas develops. The finding provides a clue to how it may be possible to 'programme' stem cells - master cells in the body that can develop into specialised cells - to become pancreatic cells. Pancreatic agenesis is a rare condition in which the body is unable to produce a pancreas...
  2011-12-13
Dapagliflozin Plus Glimepiride Lowered Blood Glucose Levels Over 48 Weeks Of Treatment
  • Results from a Phase III clinical study, announced on December 8th by Bristol-Myers Squibb Company and AstraZeneca, demonstrated that observed reductions in blood glucose levels (glycosylated hemoglobin levels, or HbA1c) at 24 weeks in adults with type 2 diabetes, who were treated with the investigational compound dapagliflozin added to current glimepiride (sulphonylurea) tre...
  2011-12-12
Lower Incidence Of Cardiovascular Events With Sitagliptin Compared To Sulphonylureas
  • The incidence of cardiovascular events in patients with type 2 diabetes treated with the DPP-4 inhibitor sitagliptin (Januvia) is significantly lower than in those treated with sulphonylureas, show reveals from a pooled analysis reported this week at the International Diabetes Federation 2011 World Diabetes Congress (4 December 2011)...
  2011-12-09
Women On Rotating Night-Shifts At Increased Risk Of Type 2 Diabetes, Weight Gain
  • In women, there is a positive association between rotating night shift work and the risk of developing type 2 diabetes and, furthermore, long duration of shift work may be associated with greater weight gain...
  2011-12-08
Shift Work Carries Diabetes Risk
  • A new study published in this week's PLoS Medicine, shows type 2 diabetes risk is increased by rotating shift work. A fairly significant proportion of the work force is involved in some kind of permanent night or rotating night shift work, thus the findings present a potential public health issue...
  2011-12-07
Link Between Low Vitamin D Levels And Higher Degrees Of Insulin Resistance
  • A recent study of obese and non-obese children found that low vitamin D levels are significantly more prevalent in obese children and are associated with risk factors for type 2 diabetes. This study was accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM)...
  2011-12-06
Patients With Type 2 Diabetes And Depression At Increased Risk Of Dementia
  • Depression in patients with diabetes is associated with a substantively increased risk of development of dementia compared to those with diabetes alone, according to researchers from the University of Washington and Kaiser Permanente...
  2011-12-06
World's First View Of Type 1 Diabetes As It Unfolds
  • A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view-- until now. Researchers at the La Jolla Institute for Allergy & Immunology have created the first cellular movies showing the destruction underlying type 1 diabetes in real-time in mouse models...
  2011-12-05
Diabetes Type 1 As It Unfolds - First View Ever By La Jolla Institute
  • In millions of people worldwide, the pancreas is under attack! Damage to cells in the pancreas leads to type 1 diabetes, this destruction has largely been hidden from view - until now...
  2011-12-03
La Jolla Institute Researchers Provide World's First View Of Type 1 Diabetes As-It-Unfolds
  • A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view-- until now. Researchers at the La Jolla Institute for Allergy & Immunology have created the first cellular movies showing the destruction underlying type 1 diabetes in real-time in mouse models...
  2011-12-03
Prediction Tools Can Aid Diabetes Prevention
  • New research from Queen Mary, University of London suggests that many cases of diabetes could be prevented by making use of existing prediction tools. The study, published in the British Medical Journal, shows that there are dozens of different techniques for predicting with reasonable accuracy who will develop diabetes but almost none are currently being used...
  2011-12-01
Potential For Novel Therapies For The Treatment Of Diabetes
  • Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that its scientists have demonstrated that, in the presence of GLP-1, glucagon-like-peptide-1 receptor (GLP1R) can form a heterodimer receptor complex with gastric-inhibitory-peptide-receptor (GIPR)...
  2011-11-29
Obese Patients With Diabetes Experience Improved Heart Function Following Restricted Calorie Diet
  • A low-calorie diet eliminates insulin dependence and leads to improved heart function in obese patients with type 2 diabetes, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA). "Lifestyle interventions may have more powerful beneficial cardiac effects than medication in these patients," said the study's lead author, Sebastiaan Hammer, M.D...
  2011-11-28
Takeda Submits New Drug Application In The U.S. For Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
  • Takeda Pharmaceutical Company Limited (Takeda) announced that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy alogliptin/metformin, which combines alogliptin with metformin in a single tablet...
  2011-11-27
Cholesterol Levels And Heart Disease Biomarkers In Diabetics Improved By Vitamin D-Fortified Yoghurt
  • People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics...
  2011-11-27
Potential New Drug For Type 1 Diabetes
  • Drug for Type 1 Diabetes Developed by Prof. Irun Cohen of the Weizmann Institute Meets Primary and Secondary Goals of Phase III Clinical Trials The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial...
  2011-11-25
Study Reveals A Natural Fatty Acid Used In Manufacturing Can Modulate Glucose Control
  • A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment. According to the U.S...
  2011-11-24
Shedding New Light On Body Parts' Sensitivity To Environmental Changes Has Implications For Diabetes
  • Research by a team of Michigan State University scientists has shed new light on why some body parts are more sensitive to environmental change than others, work that could someday lead to better ways of treating a variety of diseases, including Type-2 diabetes...
  2011-11-24
Low Blood Sugar Awareness Among Drivers With Diabetes Type 2 - UK
  • This week in the UK, a new educational campaign is being launched in order to educate individuals who live with type 2 diabetes on how to control and prevent their blood sugar levels dropping too low (hypoglycemia). The campaign, titles "Are You Running On Empty", is a collaboration between MSD Diabetes, Diabetes Nursing Group, the AA (Automobile Association) and TREND...
  2011-11-23
American Diabetes Association's Preferred Testing Method Shown To Fail At Identifying Children With Diabetes
  • In 2009, the American Diabetes Association (ADA) recommended that Hemoglobin A1c be exclusively used for the diagnosis of diabetes in children. The simple test measures longer-term blood sugar levels -- without requiring patients to fast overnight. However, a new U-M study has shown that these tests are not very accurate in children...
  2011-11-22
Researchers Develop Tool That Saves Time, Eliminates Mistakes In Diabetes Care
  • In the fast-paced world of health care, doctors are often pressed for time during patient visits. Researchers at the University of Missouri developed a tool that allows doctors to view electronic information about patients' health conditions related to diabetes on a single computer screen...
  2011-11-22
New Driving Licenses Won't Affect Your Driving Status, Doctors Tell Diabetes Patients, UK
  • In the UK individuals with diabetes are being reassured by doctors that new changes to the way driving licenses are issued will not end their days behind the wheel...
  2011-11-21
U.S. Food And Drug Administration (FDA) Delays Review Of Takeda's Investigational Type 2 Diabetes Therapies, Alogliptin And Alogliptin/Pioglitazone
  • Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., today announced that the company received notification from the U.S. Food and Drug Administration (FDA) that its review of investigational type 2 diabetes therapy alogliptin, and thus the fixed-dose combination therapy alogliptin/pioglitazone, will be delayed...
  2011-11-19
The Canadian Diabetes Association Announces Elsevier As New Publisher Of The Canadian Journal Of Diabetes Starting In 2012
  • The Canadian Diabetes Association is pleased to announce that it has entered into an agreement with Elsevier to publish the Canadian Journal of Diabetes (CJD) beginning in January 2012. CJD is Canada's only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes healthcare professionals and scientists...
  2011-11-19
Molecular Link Between Diabetes And Cancer Described
  • The fact that diabetes raises the risk of certain types of cancer is already well known, but the reasons have been unclear. Now researchers at Lund University in Sweden have mapped a molecular link that explains the connection between the two widespread diseases. Developing type 2 diabetes is a lengthy process. An early sign that it has begun is high levels of insulin in the blood...
  2011-11-16
AMD-Like Lesions Delayed In Mice Fed Lower Glycemic Index Diet
  • Feeding older mice a lower glycemic index (GI) diet consisting of slowly-digested carbohydrates delays the onset of age-related, sight-threatening retinal lesions, according to a new study from the Laboratory for Nutrition and Vision Research at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University...
  2011-11-15
In Type 1 Diabetes, Intensive Therapy Halves Kidney Disease
  • Controlling blood glucose early in the course of type 1 diabetes yields huge dividends, preserving kidney function for decades. The new finding from a study funded by the National Institutes of Health was published online in the New England Journal of Medicine to coincide with presentation at a scientific meeting...
  2011-11-15
Sitagliptin Is Safer And As Effective As Glipizide In Patients With Type 2 Diabetes And Chronic Kidney Disease
  • Some blood-sugar-lowering drugs have caused kidney problems in patients with type 2 diabetes, so physicians are especially cautious when prescribing these agents to diabetics who also have chronic kidney disease (CKD). Previous research indicates that the diabetes drugs sitagliptin and glipizide may not cause considerable kidney damage...
  2011-11-15
The COBRA Trial Results Reported At TCT 2011
  • A clinical trial of patients with diabetes has demonstrated that cryoplasty post-dilitation compared to conventional balloon angioplasty in the superficial femoral artery (SFA) decreased the risk of in-stent restenosis (ISR)...
  2011-11-14
Insulin Sensitivity Boosted By Knocking Out Key Protein In Mice
  • By knocking out a key regulatory protein, scientists at the University of California, San Diego School of Medicine and the Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland dramatically boosted insulin sensitivity in lab mice, an achievement that opens a new door for drug development and the treatment of diabetes...
  2011-11-13
Diabetics With Kidney Failure Shouldn't Lower Their Blood Glucose As Much As Diabetics Without Kidney Failure
  • Highlights Diabetic patients with kidney failure benefit the most when their hemoglobin A1C levels, which reflect blood glucose levels, are between 7% and 8%. For diabetics who need dialysis, hemoglobin A1C levels of 8% or greater or less than 7% put them at increased risk of dying prematurely compared to patients with levels between 7.0% and 7.9%...
  2011-11-12
Using Tears To Monitor Diabetes Blood Sugar Levels
  • Rather than going through the cumbersome and sometimes painful routine of drawing blood, diabetes patients may be able to use their tears, researchers from the University of Michigan reported in Analytical Chemistry. In animal studies, the scientists found that glucose levels from the tears of rabbits could accurately measure blood glucose (sugar) levels using an electrochemical sensor device...
  2011-11-12
Eating Fish Can Reduce The Risk Of Diabetes
  • A study analyses the dietary patterns of the adult Spanish population with high cardiovascular risk. The results reveal a high consumption of both red meat and fish. However, whilst eating lots of cured meats is associated with greater weight gain and a higher obesity rate, the consumption of fish is linked to lower glucose concentrations and a smaller risk of developing diabetes...
  2011-11-12
One Molecule For Muscle Growth And Insulin Sensitivity
  • Two independent studies in the Nov. 11 issue of the journal Cell, a Cell Press publication, suggest a common way to pump up muscles and prevent diabetes. The key is a molecule required for fine-tuning metabolism by selectively and subtly modifying core metabolic programs...
  2011-11-11
Testing Blood Sugar In Diabetes Via Tear Drops
  • Scientists are reporting development and successful laboratory testing of an electrochemical sensor device that has the potential to measure blood sugar levels from tears instead of blood - an advance that could save the world's 350 million diabetes patients the discomfort of pricking their fingers for droplets of blood used in traditional blood sugar tests...
  2011-11-11
Diabetes Associated With Inflammatory Processes That Lead To Cortical Atrophy And Brain Dysfunction
  • Many complications of diabetes, including kidney disease, foot problems and vision problems are generally well recognized. But the disease's impact on the brain is often overlooked...
  2011-11-10
Blame Does A Body Bad: New Study Links Attitudes To Diabetes Management
  • Genetics play a critical role in developing diabetes. So do eating properly, exercising and not smoking...
  2011-11-09
Protection To Cells Destroyed In Type 1 Diabetes Provided By Connexins
  • Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone insulin, which regulates blood glucose levels...
  2011-11-08
Study Indicates Brain Plays Role In Regulating Blood Sugar In Humans
  • Researchers at Albert Einstein College of Medicine of Yeshiva University have demonstrated for the first time that the brain is a key player in regulating glucose (sugar) metabolism in humans. The findings, published today in the online edition of the Journal of Clinical Investigation, suggest that drugs targeting the brain and central nervous system could be a novel approach to treating diabetes...
  2011-11-08
Preventing Diabetic Kidney Failure
  • The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers. "We believe these arginase inhibitors may be one of the new targets that can slow down the progression of, or even prevent the development of, end-stage renal disease," said Alaa S...
  2011-11-08
Exercise And Vegetarian Diet Offer Protection Against Diabetes In Black Population
  • New research shows that following a vegetarian diet and exercising at least three times a week significantly reduced the risk of diabetes in African Americans, who are twice as likely to be diagnosed with diabetes when compared to non-Hispanic whites...
  2011-11-07
NIDDK Boosts Study On Diabetic Retinopathy And Nephropathy Protections
  • Joslin Diabetes Center has received a $3.9 million DP3 grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to identify protective factors that enable many Joslin 50-Year Medalists to remain free of commonly occurring diabetes complications...
  2011-11-04
Study Shows Exenatide (Byetta) Has Rapid, Powerful Anti-Inflammatory Effect
  • Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown. The study of the drug, marketed under the trade name Byetta, was published recently in the Journal of Clinical Endocrinology and Metabolism...
  2011-11-04
Researchers Use A Diabetes Drug To Permanently Reprogram Insulin-Producing Cells
  • Pediatric researchers who tested newborn animals with an existing human drug used in adults with diabetes report that this drug, when given very early in life, prevents diabetes from developing in adult animals. If this finding can be repeated in humans, it may become a way to prevent at-risk infants from developing type 2 diabetes...
  2011-11-04
Predicting The Likelihood Of Developing Gestational Diabetes Via Age And BMI
  • Age and body mass index (BMI) are important risk factors for gestational diabetes mellitus (GDM) particularly amongst South Asian and Black African women finds new research published in BJOG: An International Journal of Obstetrics and Gynaecology. The study looked at the link between maternal age, BMI and racial origin with the development of GDM and how they interact with each other...
  2011-11-04
Acute Kidney Injury In Hospitalized Diabetic Patients Associated With Chronic Kidney Disease
  • Findings from a recent University of Cincinnati and Cincinnati Department of Veterans Affairs (VA) Medical Center study show that multiple episodes of acute kidney injury during hospital stays for patients with diabetes are associated with a risk for developing chronic kidney disease. The study is published in the November issue of the Clinical Journal of the American Society of Nephrology...
  2011-11-03
DARA Announces Positive Results From Phase 1b Clinical Study For The Treatment Of Type 2 Diabetes
  • DARA BioSciences, Inc. (NASDAQ: DARA), announces the positive results from a successfully completed Phase 1b clinical study for DB959, its peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist, a non-TZD oral drug in development for the treatment of type 2 diabetes...
  2011-11-02
Type 1 Diabetes Prevented In Mice
  • Researchers at the University of Colorado School of Medicine have found a specific molecule that can prevent the development of type 1 diabetes in mice and has a similar effect on human cells from diabetic patients...
  2011-11-02
50% More Diabetes Patients In UK Since 2005
  • According to the leading health charity Diabetes UK, the number of individuals in the UK diagnosed with diabetes has risen by approximately 130,000 to 2.9 million in the past year. Almost a 50% increase since data on diabetes was first published by GPs in 2005 (2 million). The increase is primarily in Type 2 diabetes cases, which is responsible for roughly 90% if all diagnoses...
  2011-11-01
VTT Identified Specific Bacteria Which Precede Autoimmune Diabetes
  • New potential avenues for early disease detection and prevention: A study led by Matej Oresic from VTT Technical Research Centre of Finland suggests that autoimmune diabetes is preceded by diminished gut microbial diversity of the Clostridium leptum subgroup, elevated plasma leptin and enhanced glucose-stimulated insulin secretion...
  2011-10-31
Ethnic Differences In Appointment Keeping Affect Health Of Diabetes Patients
  • Ethnic differences in appointment keeping may be an important factor in poor health outcomes among some minority patients with diabetes, according to a new study...
  2011-10-31
Specific Bacteria Identified Which Precede Autoimmune Diabetes
  • A study led by Matej Oresic from VTT Technical Research Centre of Finland suggests that autoimmune diabetes is preceded by diminished gut microbial diversity of the Clostridium leptum subgroup, elevated plasma leptin and enhanced glucose-stimulated insulin secretion...
  2011-10-31
Locally Released Insulin Activates Stem Cells To Produce More Gut And Stem Cells
  • A new study from University of California, Berkeley, researchers demonstrates that adult stem cells can reshape our organs in response to changes in the body and the environment, a finding that could have implications for diabetes and obesity...
  2011-10-31
Sulodexide Does Not Prevent Kidney Failure In Diabetes Patients With Kidney Disease
  • What was hoped to be a promising new drug to protect the kidneys has failed to benefit diabetes patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results call into question the usefulness of the drug sulodexide...
  2011-10-30
Pyridorin May Help Slow Or Prevent The Progression Of Mild Kidney Disease In Some Patients With Diabetes
  • A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The drug may benefit increasing numbers of patients as the prevalence of diabetes rises...
  2011-10-30
World's Largest Diabetes Study Targeting Foot Ulcers
  • What's crucial for a diabetic's foot sore to heal is that the ulcer is superficial, blood circulation is normal, and the person has had diabetes for a short time. This is shown in the world's largest diabetes study regarding foot ulcers, which has been carried out by the researcher Magdalena Annersten Gerhater at Malmo University in Sweden. Diabetes is becoming more and more common...
  2011-10-27
No Correlation Discovered Between Primary Kidney Stone Treatment And Diabetes
  • A Mayo Clinic study finds no correlation between the use of shock waves to break up kidney stones and the long-term development of diabetes. The study was released during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx) in Rancho Mirage, Calif...
  2011-10-24
Experimental Drug Might Protect Patients From Diabetic Dyslipidemia
  • Scientists have discovered a molecule that is highly active in inhibiting the intestinal absorption of lipids, making it an excellent candidate for fighting dyslipidemia and associated cardiac events, especially in diabetics. According to WHO, about 230 million people suffer from Type II diabetes worldwide, with estimations projecting these figures will rise to 400 million by 2025...
  2011-10-23
Halozyme Announces Positive Results From Phase 2 Ultrafast Insulin Trials In Patients With Type 1 And Type 2 Diabetes
  • Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced positive results from two Phase 2 clinical trials of its ultrafast PH20 insulin analog formulations in patients with Type 1 and Type 2 diabetes...
  2011-10-22
Gestational Diabetes In African-American Women Increases Risk Of Type 2 Diabetes
  • African American women who develop gestational diabetes mellitus during pregnancy face a 52 percent increased risk of developing diabetes in the future compared to white women who develop GDM during pregnancy, according to a Kaiser Permanente study published online in the journal Diabetologia. African American women are less likely to develop GDM during pregnancy...
  2011-10-21
Type 1 Diabetes Treatment Cost Could Rise Considerably
  • In Australia the cost of treating individuals with Type 1 diabetes is a staggering $170 billion, and this figure could double to $340bn. Worldwide approximately 220 million individuals are affected by diabetes - the fastest growing chronic disease in the world. In Australia it is estimated that 1...
  2011-10-20
Halozyme Announces Positive Results From Roche's Subcutaneous Herceptin Phase 3 Trial
  • Halozyme Therapeutics, Inc...
  2011-10-19
Takeda Initiates Phase 3 Clinical Trial Program In The United States, Latin America, And Europe For Investigational Type 2 Diabetes Therapy TAK-875
  • Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc. ("TGRD U.S."), and Takeda Global Research & Development Centre (Europe), Ltd. ("TGRD Europe"), announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes...
  2011-10-19
JCI Online Early Table Of Contents: Oct. 17, 2011
  • HEMATOLOGY: Linking high levels of blood glucose to complications of diabetes The number of individuals with type 2 diabetes is reaching epidemic proportions. Among the complications of type 2 diabetes is increased morbidity and mortality from cardiovascular disease (a group of diseases of the heart or blood vessels that includes those that cause heart attack and stroke)...
  2011-10-19
New Provincial Atlas; Information On Lab Testing Key To Managing Diabetes Among Albertans
  • A report just released by the Alberta Diabetes Surveillance System (ADSS) shows a need for more teamwork among patients and their health-care providers and more effective use of medical records to aid Albertans with getting the laboratory tests necessary to help manage and prevent long-term complications of the disease...
  2011-10-18
Study Finds Clue To Birth Defects In Babies Of Mothers With Diabetes
  • In a paper published today in Diabetologia, a team at Joslin Diabetes Center, headed by Mary R. Loeken, PhD, has identified the enzyme AMP kinase (AMPK) as key to the molecular mechanism that significantly increases the risk of neural tube defects such as spina bifida and some heart defects among babies born to women with diabetes...
  2011-10-18
JDRF-Funded Scientists Breathe New Life Into Aging Beta Cells
  • As a person ages, the ability of their beta cells to divide and make new beta cells declines. By the time children reach the age of 10 to 12 years, the ability of their insulin-producing cells to replicate greatly diminishes...
  2011-10-14
Discovery Of New Molecular Target For Diabetes Treatment
  • Researchers at the Stanford University School of Medicine have identified a key molecular pathway responsible for the natural decrease in the proliferation of insulin-producing cells that occurs as a person ages. Artificially activating this pathway, which is normally not functional in adults, may be a new way to combat diabetes...
  2011-10-13
Diabetes Doesn't Mean Kids Have To Skip Halloween
  • Ghosts, ghouls and goblins are suiting up for the yearly pilgrimage through neighborhoods shouting "Trick or Treat!" and begging for sweet treats that are synonymous with Halloween. But a candy-centric holiday poses challenging questions for parents of children with diabetes...
  2011-10-12
Continuous Glucose Monitoring Beneficial In Maintaining Target Blood Glucose Levels For People With Diabetes
  • Patients with diabetes face daily challenges in managing their blood glucose levels, and it has been postulated that patients could benefit from a system providing continuous real-time glucose readings. Today, The Endocrine Society released a clinical practice guideline (CPG) providing recommendations on settings where patients are most likely to benefit from continuous glucose monitoring (CGM)...
  2011-10-12
Caloric Restriction Improves Insulin Action
  • The number of individuals with type 2 diabetes is reaching epidemic proportions. One of the main risk factors for developing type 2 diabetes is resistance of cells in the body (particularly liver, fat, and skeletal muscle cells) to the effects of the hormone insulin. Substantially reducing caloric intake enhances the sensitivity of skeletal muscle to insulin...
  2011-10-11
Cardium Announces Excellagen FDA 510(K) Clearance
  • Cardium Therapeutics (NYSE Amex: CXM) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen™ professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds...
  2011-10-11
Diabetes Patients Who Raise Their 'Good' Cholesterol Levels Reduce Their Risk Of Heart Attack And Stroke
  • Increasing levels of high-density lipoproteins, better known as HDL or "good" cholesterol, reduced the risk for heart attack and stroke among patients with diabetes. That's according to a new study appearing online in The American Journal of Cardiology...
  2011-10-10
Using Diabetic Patients' Own Stem Cells Can Overcome Shortage Of Insulin-producing Cells Without The Need For Gene Transfer
  • Researchers in Japan have discovered how a patient's neural stem cells could be used as an alternative source of the beta cells needed for a regenerative treatment for diabetes. The research, published in EMBO Molecular Medicine, reveals how harvesting stem cells could overcome a lack of beta cell transplants from donors...
  2011-10-09
Diabetes Susceptibility Gene Identified: Tomosyn-2 Regulates Insulin Secretion
  • A group of researchers from the University of Wisconsin-Madison has pinpointed a gene that confers diabetes susceptibility in obese mice. Published in the open-access journal PLoS Genetics, this study also shows that its protein tomosyn-2 acts as a brake on insulin secretion from the pancreas...
  2011-10-09
Tomosyn-2 The Diabetes Susceptibility Gene - It Regulates Insulin Secretion
  • In a study published in the open-access journal PLoS Genetics on October 6th, a research team from the University of Wisconsin-Madison has identified a gene called tomosyn-2 that confers diabetes susceptibility in obese mice and acts as an inhibitor on insulin secretion from the pancreas...
  2011-10-09
FDA Approves Combination Therapy Juvisync
  • The U.S. Food and Drug Administration approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin. About 20 million people in the United States have type 2 diabetes, and they often have high cholesterol levels as well...
  2011-10-08
Decade Of Effort Yields Diabetes Susceptibility Gene
  • Ten years of meticulous mouse breeding, screening, and record-keeping have finally paid off for Alan Attie and his lab members. The University of Wisconsin Madison researchers' efforts, published Oct. 6 in the journal PLoS Genetics, pinpointed a gene that confers diabetes susceptibility in obese mice...
  2011-10-07
Novo Nordisk Partners With Greater Boston Area Community Organizations To Create Programming For Diabetes
  • Leading diabetes healthcare company Novo Nordisk announced today that it has awarded $150,000 in sponsorships to nine Greater Boston community organizations to support programs that educate people living with type 2 diabetes to help them reduce their risks for long term complications...
  2011-10-06
Vitamin D Could Lower Risk Of Developing Type 2 Diabetes
  • Scientists at the Helmholtz Zentrum München have shown that people with a good vitamin D supply are at lower risk of developing Type 2 diabetes mellitus. The study, which was conducted in cooperation with the German Diabetes Center and the University of Ulm, will be published in the October edition of the renowned scientific journal Diabetes Care...
  2011-10-05
Natural Compound Helps Reverse Diabetes In Mice
  • Researchers at Washington University School of Medicine in St. Louis have restored normal blood sugar metabolism in diabetic mice using a compound the body makes naturally. The finding suggests that it may one day be possible for people to take the compound much like a daily vitamin as a way to treat or even prevent type 2 diabetes...
  2011-10-05
News From The Journal Of Clinical Investigation: Oct. 3, 2011
  • METABOLIC DISEASE: Antioxidants combat risk factor for type 2 diabetes in mice The number of individuals with type 2 diabetes is reaching epidemic proportions. One of the main risk factors for developing type 2 diabetes is resistance of the cells in the body to the effects of the hormone insulin...
  2011-10-04
Men Don't Have To Be As Fat As Women To Get Type 2 Diabetes
  • Men develop type 2 diabetes at a lower BMI (body mass index) than women, according to a new study by clinical researchers in Scotland expected to be published in a scientific journal this week. Their findings may explain why in many countries, men are more prone to the disease than women...
  2011-10-04
Oral Health Of Diabetes Patients Closely Linked To Heart Disease And Cancer Risk
  • According to researchers in the report "Oral health awareness in adult patients with diabetes: a questionnaire study", published in the latest issue of the British Dental Journal (BDJ), several individuals who suffer with diabetes are not aware that their oral health is closely connected to their risk of developing complications...
  2011-10-03
The Hormonal Role In Glucose And Fat Metabolism Explained
  • Hormone researchers at the University of Houston (UH) have their sights set on providing long-term treatment options for diabetes, obesity and cardiovascular diseases by better understanding estradiol, the most potent naturally occurring estrogen. They now believe that this estrogen hormone is a prominent regulator of several body functions in both females and males...
  2011-10-03
New Therapeutic Approach To Diabetes And Obesity Suggested By Powerful Antibody-Based Strategy
  • The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs...
  2011-10-02
Study Shows Survival Of Diabetic CABG Patients Not Improved By Aggressive Glycemic Control
  • Findings published in this month's issue of Annals of Surgery revealed that surgeons from the Boston Medical Center (BMC) discovered that in clinical outcomes, diabetic patients undergoing coronary artery bypass graft (CABG) surgery do not show significant improvements with aggressive glycemic control compared with moderate control...
  2011-09-30
No Slowing Of Cognitive Decline With Intensive Blood Sugar Control In Type 2 Diabetes
  • Researchers who compared intensive glucose-lowering treatment with standard glucose control in older patients with type 2 diabetes found that contrary to expectations, super-tight control of blood sugar did not slow the mental decline of diabetes-related dementia, and in the case of their study participants, it was actually linked to a higher rate of death...
  2011-09-30
Large Meta-Analysis Finds New Genes For Type 1 Diabetes
  • The largest-ever analysis of genetic data related to type 1 diabetes has uncovered new genes associated with the common metabolic disease, which affects 200 million people worldwide. The findings add to knowledge of gene networks involved in the origin of this complex disorder, in which patients depend on frequent insulin injections to control their blood sugar levels...
  2011-09-30
Key Protein Identified That Causes Excess Production Of Glucose In The Livers Of Diabetics
  • Researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine have identified a powerful molecular pathway that regulates the liver's management of insulin and new glucose production, which could lead to new therapies for diabetes...
  2011-09-30
Diabetes Patients Have Higher Colon Cancer Risk
  • Patients with diabetes mellitus have a higher risk of developing colon cancer, researchers from the University of California, Berkeley, reported in the American Journal of Gastroenterology. The authors stated that according to their findings, diabetes is an independent risk fact for rectal and colon cancers...
  2011-09-29
Diabetics That Visit Physicians More Frequently Have Improved Risk Factors
  • A report in the September 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals shows that diabetics who visit a primary care clinician twice a month have greater control of blood glucose, blood pressure and cholesterol levels. As per background information in the article, diabetes has become increasingly common in the U.S. and worldwide...
  2011-09-28
News From The Journal Of Clinical Investigation: September 26, 2011
  • ENDOCRINOLOGY: Rare genetic disease yields insight into biology of cells affected in diabetes Congenital hyperinsulinism of infancy (CHI) is a rare genetic disease characterized by dysregulation of beta-cells in the pancreas such that they secrete excessive amounts of the hormone insulin, which leads to very low levels of glucose (the fuel for cells in the body) in the blood...
  2011-09-27
Control Of Diabetes Linked To Frequency Of Doctor Visits
  • According to a study by investigators at Brigham and Women's Hospital (BWH) published in the September 26, 2011, issue of Archives of Internal Medicine, high blood glucose, blood pressure and cholesterol levels increase the risk for complications related to diabetes, such as heart attack and stroke, and in order to reduce these risks these values should be reduced to ideal levels...
  2011-09-27
Discovery Of Insulin Switches In Pancreas Could Lead To New Diabetes Drugs
  • Researchers at the Salk Institute have discovered how a hormone turns on a series of molecular switches inside the pancreas that increases production of insulin...
  2011-09-27
UN Discussions Focus On Non-Communicable Diseases
  • The European Chronic Disease Alliance (ECDA)1 welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world biggest killers. "It is a memorable day in the history of public health...
  2011-09-26
Dietary Supplement May Lower Risk Of Developing Type 2 Diabetes
  • FINDINGS: UCLA researchers demonstrated that an over-the-counter dietary supplement may help inhibit development of insulin resistance and glucose intolerance, conditions that are involved in the development of Type 2 diabetes and metabolic syndrome, which affect millions worldwide...
  2011-09-25
Dietary Supplement May Lower Risk Of Developing Type 2 Diabetes, Metabolic Syndrome
  • UCLA researchers demonstrated that an over-the-counter dietary supplement may help inhibit development of insulin resistance and glucose intolerance, conditions that are involved in the development of Type 2 diabetes and metabolic syndrome, which affect millions worldwide...
  2011-09-23
Clinic Bridges Inpatient, Outpatient Diabetes Care
  • After diabetes destroyed his kidney function, retired restaurateur Charles Collins received a transplant last fall that saved his life but it didn't cure his disease. In fact, it took the Diabetes Bridge Clinic at the University of Alabama at Birmingham to help Collins get to the point where he could manage his disease and keep his new kidney healthy...
  2011-09-23
The NHS Paid An Extra £625 Million On Synthetic Insulin Over The Past Decade
  • Research published online in BMJ Open reveals that the NHS paid an extra £625 million on synthetic forms of insulin over the past decade, when the considerably cheaper recommended human alternatives would have probably been just as effective...
  2011-09-22
TheraVasc Releases Phase I Trial Data Demonstrating Safety Of Drug In Diabetic Patients
  • TheraVasc announced the successful completion of a Phase I clinical trial of a drug, TV1001, to diabetic patients. The trial included 12 diabetic patients who each received a single dose of two different oral formulations of TV1001, an enteric coated and a non-enteric coated capsule, to determine safety and blood levels of the drug...
  2011-09-22
Clues To Finding Further Causes For Monogenic Diabetes
  • In most cases of diabetes, various genes and environmental factors are involved. Not in monogenic diabetes, where the causes are mutations in just a single gene. Between 25 % and 45 % of family members or patients with monogenic diabetes do not present alterations in any of the genes that have been put forward to date as possible causes, and so new candidate genes have had to be identified...
  2011-09-22
Lack Of Sleep Causes Diabetes Risk
  • An article by the American Diabetes Association in Diabetes Care links lack of sleep to higher blood sugar levels and thus possible type 2 diabetes risk...
  2011-09-21
CE Mark Approval For The World's First Mobile Diabetes Management System Received
  • According to an announcement made by Cellnovo, the company received CE Mark approval for the world's first mobile diabetes management system which is a major breakthrough for the company and for people living with diabetes. Chief Executive Officer of Cellnovo, William McKeon said: "This is Cellnovo's first step in a journey to bring this mobile diabetes management system to the world...
  2011-09-20
Once-Daily Linagliptin Reduces Blood Glucose Long Term For Diabetes Type 2 Patients
  • Results of a 102 week Phase III investigation for linagliptin (trade name Trajenta® in Europe) were announced today, and showed significant and durable reductions in blood glucose levels for adults who suffer from type 2 diabetes...
  2011-09-19
Possible Link Between Two Diabetes Drugs And Pancreatic Cancer
  • Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according to a new UCLA study. Researchers from the Larry L. Hillblom Islet Research Center at UCLA examined the U.S...
  2011-09-17
Generex Makes Podium Presentation Of Clinical Data On Generex Oral-lyn™ At European Association For The Study Of Diabetes Annual Meeting
  • Generex Biotechnology Corporation (OTCBB: GNBT) announced that Dr. Nicola Napolii, from University Campus Bio-Medico in Rome, Italy, made a podium presentation of the clinical data on Generex Oral-lyn™ buccal insulin spray on September 14, 2011 at the European Association for the Study of Diabetes (EASD) annual meeting in Lisbon, Portugal. Dr...
  2011-09-17
ChemoCentryx Reports CCX140-B Meets Primary Endpoint And Demonstrates Clinical Efficacy In Phase II Study In Type 2 Diabetes
  • ChemoCentryx, Inc. today announced that the Company's novel, orally active CCR2 antagonist, CCX140-B, demonstrated an excellent safety profile and exhibited clear signs of biological and clinical effect in a Phase II study in patients with type 2 diabetes on stable doses of metformin...
  2011-09-16
Uterine Stem Cells Treat Diabetes In Mouse Model
  • Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published in the journal Molecular Therapy. The team treated diabetes in mice by converting cells from the uterine lining into insulin-producing cells. The endometrium or uterine lining, is a source of adult stem cells...
  2011-09-16
Galvus® (Vildagliptin) Achieves Significant Improvement In Type-2 Diabetes Treatment
  • At the 47th Annual Meeting of the European Association for the Study of Diabetes Novartis announced results of a study that revealed Galvus® (vildagliptin) has a similar safety profile to placebo when added to anti-diabetic therapy in patients with type 2 diabetes (T2DM) and moderate or severe renal impairment...
  2011-09-15
Diabetic Patients Underappreciate Hypoglycemia
  • Despite the risks of untreated hypoglycemia, nearly a third of patients with type 2 diabetes acknowledge that they do not routinely discuss the condition with their physician, new data show...
  2011-09-15
366 Million Diabetics Worldwide, Alarming Death Rates As Epidemic Continues To Worsen
  • One person dies from diabetes every seven seconds, in a worldwide diabetes epidemic that continues to worsen, with 366 million diabetics worldwide, an annual death count of 4.6 million, and a health care bill of 465 billion US dollars...
  2011-09-14
Diabetes Public Health: Study Highlights Need For Better Guidelines
  • A survey of federally funded diabetes prevention and control programs in 57 U.S. states and territories has highlighted the need for better diabetes treatment guidelines that are specifically adapted to different populations. Such guidelines do not currently exist...
  2011-09-14
Hope For Patients With Juvenile Diabetes Following Discovery Of Key Signal That Prompts Production Of Insulin-Producing Beta Cells
  • Researchers at the Hebrew University of Jerusalem have identified the key signal that prompts production of insulin-producing beta cells in the pancreas - a breakthrough discovery that may ultimately help researchers find ways to restore or increase beta cell function in people with type 1 diabetes. The work on the multi-year project was led by Prof...
  2011-09-13
Analyses Find Type 2 Diabetes Patients Treated With BYDUREON™ Experienced Reduction In Cardiovascular Risk Factors: Results Presented At EASD 20
  • Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc...
  2011-09-13
New Data On EMA401 In Model Of Diabetic Neuropathy Presented At 21st Annual NEURODIAB Meeting
  • Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy. EMA401 is an angiotensin II type 2 (AT2) receptor antagonist currently in clinical development for a number of neuropathic pain indications...
  2011-09-13
Diabetes Type 1 - Alcohol Related Deaths Rise Significantly
  • According to a study published on bmj.com, alcohol has become an important cause of death among patients with type-1 diabetes since the 1980s...
  2011-09-11
New Twist In Diabetes Drugs Could Reduce Life-Threatening Side Effects
  • Researchers from Dana-Farber Cancer Institute in Boston and the Scripps Research Institute in Jupiter, Fla., report they have created prototype drugs having powerful anti-diabetic effects, yet apparently free at least in mice of dangerous side effects plaguing some current diabetes medications...
  2011-09-10
Improved Understanding Of Human Mitochondrial Diseases Following New Cellular Surprise Discovery
  • A surprising new discovery by the University of Colorado Boulder and the University of California, Davis regarding the division of tiny "power plants" within cells known as mitochondria has implications for better understanding a wide variety of human diseases and conditions due to mitochondrial defects...
  2011-09-08
Shape-Shifting Mechanism Critical To Protein Signaling Discovered: Findings Show How Form Controls Function In Sought-After Therapeutic Target
  • In a joint study, scientists from the California and Florida campuses of The Scripps Research Institute have shown that changes in a protein's structure can change its signaling function and they have pinpointed the precise regions where those changes take place...
  2011-09-08
New Ways Discovered To Stimulate Pancreatic Beta Cell Growth
  • One of the holy grails in diabetes research is to discover molecules that stimulate beta cell growth and to find drugs that target these molecules. Now, JDRF-funded researchers in collaboration with the pharmaceutical company Hoffmann-La Roche, have done both, discovering not only a protein that regulates beta cell growth, but also a chemical compound that stimulates it...
  2011-09-08
Newly Identified Protein Required For Glucose Uptake
  • All cells need glucose (sugar) to produce the energy they need to survive. High glucose levels in the bloodstream (such as occur after a meal), trigger the pancreas to produce insulin. In turn, muscle and fat cells respond to insulin by moving GLUT4, a glucose transporter, from intracellular storage out to the cell surface. There, GLUT4 can take up the glucose the cell needs from the bloodstream...
  2011-09-08
Biomaterials May Prove Key To Healing Chronic Wounds In Diabetic Patients
  • Biomaterials may prove key to healing chronic wounds in Diabetic patients, delegates will hear today at the 24th European Conference on Biomaterials. Over 950 delegates are at the event in Dublin, which is jointly hosted by NUI Galway's Network of Excellence for Functional Biomaterials and the University of Ulster, Jordanstown...
  2011-09-07
Fetal Tissue Plays Pivotal Role In Formation Of Insulin-Producing Cells
  • A somewhat mysterious soft tissue found in the fetus during early development in the womb plays a pivotal role in the formation of mature beta cells the sole source of the body's insulin. This discovery, made by scientists at University of California, San Francisco (UCSF) and Texas A&M University, may lead to new ways of addressing Type 1 and Type 2 diabetes...
  2011-09-07
News From The Annals Of Internal Medicine: Sept. 6, 2011
  • Making Multiple Lifestyle Improvements Can Significantly Reduce Diabetes Risk It is well-documented that lifestyle factors such as diet, weight, physical activity, smoking habits, and alcohol consumption affect a person's risk for diabetes. Studies have shown that individual lifestyle improvements, such as quitting smoking, can delay or prevent the onset of diabetes...
  2011-09-07
New Tactic For Controlling Blood Sugar In Diabetes Contradicts Current View Of The Disease
  • Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes...
  2011-09-06
New Class Of Anti-Diabetic Compound Established By Scripps Research Scientists
  • In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch...
  2011-09-06
DMP For Diabetes Type 1: Guidelines Indicate Some Need For Revision
  • On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1...
  2011-09-06
Inflammation In Diabetes May Be Part Of The Solution, Not The Problem
  • Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes...
  2011-09-06
Diabetes Risk 80% Lower For Those With Multiple Good Lifestyle Factors, Compared To Those With Worst
  • Individuals with good lifestyle factors, such as not over-consuming alcohol, eating a healthy diet, doing exercise, not smoking and being of normal weight, are 80% less likely to develop Diabetes Type 2 over an 11-year period, compared to those with bad lifestyle factors, researchers from the National Heart, Lung, and Blood Institute, Bethesda, and National Cancer Institute, Ro...
  2011-09-06
Metabolic Syndrome Prevented By Powerful Antioxidant Resveratrol In Lab Tests
  • Researchers in the Faculty of Medicine & Dentistry at the University of Alberta have discovered that resveratrol, a powerful antioxidant found in common foods, prevents a syndrome in some offspring that could lead to later health issues such as diabetes. Resveratrol is found in fruits, nuts and red wine, and has been shown to extend the lifespan of many species...
  2011-09-05
How Cells' Powerhouse Divides - New Insight
  • New research from the University of California, Davis, and the University of Colorado at Boulder puts an unexpected twist on how mitochondria, the energy-generating structures within cells, divide. The work, which could have implications for a wide range of diseases and conditions, was published today in the journal Science...
  2011-09-05
Crippling Condition Associated With Diabetes Is Often Misdiagnosed And Misunderstood
  • Robert Winkler says he limped around on his painful left foot for six months, suffering unnecessarily from a misdiagnosis by a physician who didn't know about the symptoms and treatments for Charcot foot, a form of localized osteoporosis linked to diabetes that causes the bones to soften and break, often resulting in amputation. When his primary care physician finally agreed to Mr...
  2011-09-05
The Effects Of Airplane Travel On Insulin Pump Delivery: More Questions Than Answers Remain
  • Despite recent concerns that changes in atmospheric pressure during airplane travel may affect the amount of insulin delivered via pump devices, the current evidence is limited and it would be unwise to overreact until more data are available, according to an insightful editorial in Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc...
  2011-09-01
Opticians Could Enable Early Identification Of Diabetes With A Simple Blood Test
  • A simple finger prick test during routine eye examinations at high street opticians could help to identify millions of people with previously undiagnosed Type 2 diabetes, according to new research...
  2011-09-01
Sweat Meter Warns Patients Of Dangerously Low Blood Sugar
  • Some diabetic patients receive no warning before they pass out from low blood sugar. A modern sweat meter could alert patients in time. Biathletes and ME patients might also benefit from the sweat meter. By Yngve Vogt, research magazine Apollon, University of Oslo, Norway 25,000 Norwegians have type 1 diabetes. 175,000 have type 2 diabetes...
  2011-08-31
Identification Of Six New Genetic Variants Linked To Type 2 Diabetes In South Asians
  • An international team of researchers led by Imperial College London has identified six new genetic variants associated with type-2 diabetes in South Asians. The findings, published in Nature Genetics, give scientists new leads in the search for diagnostic markers and drug targets to prevent and treat this major disease...
  2011-08-30
Inactivity Linked With Risk Factors For Type 2 Diabetes
  • 79 million American adults have prediabetes and will likely develop diabetes later in life, according to the Centers for Disease Control and Prevention. As the number of people diagnosed with diabetes continues to grow, researchers are focusing on discovering why the prevalence of the disease is increasing...
  2011-08-25
Researchers Identify New Target For Treatment Of Type 2 Diabetes And Prediabetes
  • Researchers at the Joslin Diabetes Center have shown that an enzyme found in the mitochondria of cells is decreased in the skeletal muscle of those with type 2 diabetes, a finding that could lead to the development of drugs to boost the activity of this enzyme in an effort to fight the disease...
  2011-08-23
The Complex Relationship Between Exercise And Metformin
  • It's common enough for researchers to look at the impacts of prescribed drugs on the body. And if you're a diabetes researcher who believes that exercise has great benefits for those with type 2 diabetes, you're hoping your research will show that...
  2011-08-22
Waist Circumference Not A Better Predictor Of Diabetes Risk Than Body Mass Index In U.S. Adolescents
  • Waist circumference, a measure of belly fat, is not a better predictor than body mass index for identifying children with an increased risk of developing type 2 diabetes, according to a study by University of Michigan researchers. Results of the study, led by U-M C.S. Mott Children's Hospital pediatric endocrinologist Joyce M. Lee, M.D., M.P.H...
  2011-08-20
Study Focuses On Relationship Between Glaucoma And Diabetes, Hypertension
  • Many Americans suffer from diabetes and hypertension and, according to a study by researchers at the University of Michigan Kellogg Eye Center, these individuals may have an increased risk of developing open-angle glaucoma (OAG). Joshua D. Stein, M.D., M.S...
  2011-08-18
Red And Processed Meats Increase Diabetes Risk; Nuts And Dairy Reverse Effect
  • A new study finds that processed products such as bologna and hot dogs, and red meat in general can increase your risk of type 2 diabetes by almost half, and that by getting your protein from other rich sources such as nuts, whole grains and dairy low in fat, it will actually have the reverse effect...
  2011-08-16
In Mouse Model, Decoding Infidelity Linked To Type 2 Diabetes
  • Type 2 diabetes is an extremely common chronic condition characterized by high levels of sugar in the blood as a result of either insufficient production of the hormone insulin or an inability of cells to respond to insulin. A combination of genetic and environmental factors causes an individual to develop type 2 diabetes...
  2011-08-16
UVA Neurology Stroke Researchers Win $25 Million NIH Grant To Reduce Debilitating Effects Of Stroke In Diabetic Patients
  • Researchers at the University of Virginia Health System have received a $25 million grant from the National Institutes of Health (NIH) to lead a 50+-center national clinical trial investigating a promising new treatment that could greatly benefit thousands of acute ischemic stroke patients every year...
  2011-08-16
How Fatty Diets Cause Diabetes
  • Newly diagnosed type 2 diabetics tend to have one thing in common: obesity. Exactly how diet and obesity trigger diabetes has long been the subject of intense scientific research. A new study led by Jamey D. Marth, Ph.D...
  2011-08-15
Intercept Pharmaceuticals And Servier Announce Agreement For Intercept's TGR5 Research Program In Type 2 Diabetes
  • Intercept Pharmaceuticals, Inc. (Intercept) and Les Laboratoires Servier (Servier) announced that they have entered into a worldwide ex-U.S. and Japan agreement for the discovery and development of novel TGR5 agonists for the treatment of type 2 diabetes and other metabolic indications...
  2011-08-13
Red Meat Linked To Increased Risk Of Type 2 Diabetes
  • A new study by Harvard School of Public Health (HSPH) researchers finds a strong association between the consumption of red meat-particularly when the meat is processed-and an increased risk of type 2 diabetes. The study also shows that replacing red meat with healthier proteins, such as low-fat dairy, nuts, or whole grains, can significantly lower the risk...
  2011-08-12
No Evidence That Heart Attack Risk Reduced By Combining Fibrate Drugs With Statins In Diabetes Patients
  • Despite facing a higher risk of cardiovascular disease, patients with type 2 diabetes often take a combination of drugs designed to lower their LDL (bad cholesterol) and triglyceride levels while raising their HDL (good cholesterol) due to the belief from doctors that taken together, the drugs offer protection from heart attacks and improve survival...
  2011-08-11
An Advance In The Prevention Of Diabetes Mellitus Following Kidney Transplantation
  • Up to 30 percent of all patients develop diabetes mellitus within the first year after a kidney transplantation. This high rate could soon fall rapidly. A Medical University of Vienna research team at Vienna General Hospital's University Department of Internal Medicine III has discovered in the context of a study that pre-emptive insulin therapy drastically reduces this rate...
  2011-08-09
Hydrogen Sulfide Protects Blood Vessels From Complications Of Diabetes
  • Hydrogen sulfide is a foul-smelling gas with an odor resembling that of rotten eggs. Sometimes called "swamp gas," this toxic substance is generally associated with decaying vegetation, sewers and noxious industrial emissions...
  2011-08-04
Type 2 Diabetes, 'Intensive' Versus 'conventional' Blood Glucose Control
  • Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional...
  2011-08-02
Mobile Phone Technology Helps Patients Manage Diabetes
  • An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers. The study is being published in the September issue of the journal Diabetes Care...
  2011-08-01
Stave Off Diabetes Insulin Resistance With Muscle Mass Training
  • It seems that hitting the gym and resistance training may not only keep you fit and looking smart, but also will lower your risk of type 2 diabetes. People who are overweight are more likely to have insulin resistance, because fat interferes with the body's ability to use insulin. Type 2 diabetes usually occurs gradually. Most people with the disease are overweight at the time of diagnosis...
  2011-07-31
$3 Million Grant To Aid Minorities With Uncontrolled Diabetes
  • Researchers at the University of Illinois at Chicago's Institute for Health Research and Policy and College of Medicine have received a $3 million federal grant to improve diabetes management in minority patients...
  2011-07-29
With Diabetes, Untreated Depression Can Lead To Serious Eye Disease
  • Patients with diabetes who also suffer from depression are more likely to develop a serious complication known as diabetic retinopathy, a disease that damages the eye's retina, a five-year study finds...
  2011-07-29
Increased Muscle Mass May Lower Risk Of Pre-Diabetes
  • A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that the greater an individual's total muscle mass, the lower the person's risk of having insulin resistance, the major precursor of type 2 diabetes...
  2011-07-29
Raise Your Muscle Mass And Reduce Your Type 2 Diabetes Risk
  • Building muscle can lower your insulin resistance risk, which in turn lowers your chances of developing pre-diabetes, and ultimately protecting you from ever suffering from diabetes type 2, researchers from the University of California in Los Angeles revealed in the Journal of Clinical Endocrinology & Metabolism. Insulin resistance is a major precursor for diabetes type 2...
  2011-07-28
Culturally Tailored Diabetes Program Provides Some Benefits For Asian Americans
  • SAN DIEGO - A culturally tailored diabetes program can help Asian Americans with type 2 diabetes achieve glycemic control that is comparable to that observed in white patients, researchers reported at the 71st Scientific Sessions of the American Diabetes Association (ADA)...
  2011-07-28
Worries Over Diabetes Mortality Rates In Status Aboriginal Adults
  • Diabetes rate increases in status Aboriginal adults in Alberta appear to be slowing compared with the general population, although diabetes is more common in status Aboriginals and death rates for this group are significantly higher than the general population, states an article in CMAJ (Canadian Medical Association Journal)...
  2011-07-26
Summer Time Foot Care, Special Awareness Needed For Diabetes Patients
  • With the peak of summer (and the heat) now upon us, many of us will take time to kick off the shoes and take a walk on the beach or maybe on a grassy field in the local park. Some may even hop into a river or creek to cool off. No worries, right? Well, for some people, relaxing barefoot comes with some concern. Specifically, those with diabetes need to pay close attention to their feet...
  2011-07-26
Lack Of Access To Blood Testing Supplies A Worry For Many UK Diabetes Type 2 Patients
  • One in every 7 patients with diabetes type 2 in the United Kingdom either does not have access to test strips, or has had his/her supplies reduced over the last 24 months. Not having access to proper supplies is a source of anxiety and worry for the majority of these patients, according to the Diabetes.co.uk April 2011 Survey...
  2011-07-25
Blood Glucose Control Measurements Help Predict Cardiovascular Disease Event Risk In Diabetes Patients
  • Predicting the risk for CVD (cardiovascular disease) events is improved by measuring the diabetes patient's HbA1c (hemoglobulin1c) levels, researchers from Brigham and Women's Hospital, Boston reported in Archives of Internal Medicine. The authors explained that diabetes is a risk factor for cardiovascular disease...
  2011-07-25
Parenting Style Impacts Type 1 Diabetes Control In Children, Adolescents
  • Parenting style can play an important role in improving glycemic control in children and adolescents with type 1 diabetes, according to a study published in the August issue of Diabetes Care and its accompanying editorial...
  2011-07-25
Shedding Light On Diabetes Trends In Alberta
  • The Alberta Diabetes Surveillance System was created in 2006 in partnership between Alberta Health and Wellness and the Institute of Health Economics...
  2011-07-24
Isis Initiates Phase 1 Study Of ISIS-PTP1BRx To Treat Type 2 Diabetes
  • Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B. ISIS-PTP1BRx is designed to increase the body's sensitivity to the natural hormone insulin, resulting in better glucose control for patients with type 2 diabetes...
  2011-07-23
Massive Enzyme Footballs Control Sugar Metabolism
  • Neutrons have shown how massive enzyme complexes inside cells might determine whether sugar is burnt for energy or stored as fat. These findings will improve understanding of diabetes and a range of metabolic diseases...
  2011-07-19
The Benefit Of Blood Glucose Lowering To Near-Normal Levels Remains Unclear
  • Indications of advantages but also of disadvantages / Fewer non-fatal heart attacks on the one hand, but more hypoglycaemic episodes on the other Whether patients with type 2 diabetes mellitus benefit from attempts to lower their blood glucose levels to near-normal levels through treatment ("intensive blood glucose control") remains an unanswered question...
  2011-07-17
Surgeons Pioneer New Ways To Treat Diabetes
  • Surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center are innovating new ways to treat diabetes using techniques from weight-loss surgery, including experimental procedures to improve blood glucose levels and address a major complication of the disease...
  2011-07-16
Dentists Can Identify People With Undiagnosed Diabetes
  • In a study, Identification of unrecognized diabetes and pre-diabetes in a dental setting, published in the July 2011 issue of the Journal of Dental Research, researchers at Columbia University College of Dental Medicine found that dental visits represented a chance to intervene in the diabetes epidemic by identifying individuals with diabetes or pre-diabetes who are unaware of their condition...
  2011-07-15
Adult-Derived Stem Cells Could Pave The Way For New Treatment Of Diabetes
  • Stem cells from early embryos can be coaxed into becoming a diverse array of specialized cells to revive and repair different areas of the body. Therapies based on these stem cells have long been contemplated for the treatment of diabetes, but have been held back by medical and ethical drawbacks...
  2011-07-14
Diabetes Outcomes, Health Improved By Health-Care Model
  • A health-care delivery model called patient-centered medical home (PCMH) increased the percentage of diabetes patients who achieved goals that reduced their sickness and death rates, according to health researchers. Pennsylvania leads the nation in implementing this new care model that promises to improve health and reduce costs of care...
  2011-07-14
Managing Type 2 Diabetes - A 'Nutty' Solution
  • Eating nuts every day could help control Type 2 diabetes and prevent its complications, according to new research from St. Michael's Hospital and the University of Toronto. In the research, published online by the journal Diabetes Care, a team of researchers led by Dr. David Jenkins (University of Toronto Department of Nutritional Sciences; St...
  2011-07-13
News From The Journal Of Clinical Investigation: July 11, 2011
  • METABOLIC DISEASE: Sex hormone protection from type 2 diabetes The incidence of obesity and its common complication, type 2 diabetes, is approaching epidemic proportions in the developed world. A key event in the development of type 2 diabetes is the failure of beta-cells in the pancreas to produce enough of the hormone insulin to meet the body's demands...
  2011-07-12
Sitagliptin Shows Anti-inflammatory Activity In Diabetics
  • The dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin exerts an anti-inflammatory effect in patients with type 2 diabetes at the cellular and molecular level, according to data reported at the 71st Scientific Sessions of the American Diabetes Association (ADA)...
  2011-07-10
Generex Provides Preliminary Results Of Generex Oral-lyn™ Clinical Trials In Patients With Type 1 Diabetes And Patients With Glucose Tolerance
  • Generex Biotechnology Corporation (OTC Bulletin Board: GNBT) announced preliminary clinical results of two major trials using the Generex Oral-lyn™ formulation that will be used for registration and marketing...
  2011-07-09
Novo Nordisk Partners With Children With Diabetes, Inc. To Help Newly Diagnosed Children With Type 1 Diabetes
  • Novo Nordisk, a world leader in diabetes care, and the advocacy organization Children with Diabetes, Inc. (CWD) announced a two-year partnership to develop and distribute resources that will help newly diagnosed children with type 1 diabetes adjust to their new lifestyle...
  2011-07-08
Gene Therapy Stimulates Protein That Blocks Immune Attack And Prevents Type 1 Diabetes In Mice
  • Increasing a specific protein in areas of the pancreas that produce insulin blocks the immune attack that causes type 1 diabetes, researchers reported in the August issue of the Journal of Clinical Investigation, published early online...
  2011-07-07
MingSight And Relin Form A Joint Venture In China To Develop A Novel Treatment For The Diabetic Eye Disease
  • Shenzhen Relin Medicine ("Relin"), a leading Chinese ophthalmic pharmaceutical company, and MingSight Pharmaceuticals ("MingSight"), an innovation driven ophthalmic R&D company, today announced the formation of a joint venture, Jiangsu MingSight-Relin Pharmaceutical Co., Ltd ("MingSight-Relin"), to develop and commercialize an innovative treatment for diabetic eye disease in China...
  2011-07-06
Increasing The Daily Dose Of Aspirin For Diabetics May Prevent Heart Attacks
  • In some cases, an apple a day may keep the doctor away, but for people with diabetes, regular, over-the-counter Aspirin may also do the job. A new study by University of Alberta researcher Scot Simpson has shed light on the use of Aspirin as a preventative measure for cardiovascular disease and reoccurrence in patients with diabetes...
  2011-07-06
Side Effects Of Diabetes Drug Traced To Fat Action
  • For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain...
  2011-07-06
Surprising Culprits Behind Cell Death From Fat And Sugar Overload
  • Excess nutrients, such as fat and sugar, don't just pack on the pounds but can push some cells in the body over the brink. Unable to tolerate this "toxic" environment, these cells commit suicide. Now, scientists at Washington University School of Medicine in St. Louis have discovered three unexpected players that help a cell overloaded with fat initiate its own demise...
  2011-07-06
ASN President Bonventre Speaks At ADA
  • ASN President Dr. Joseph V. Bonventre, MD, PhD, spoke at the American Diabetes Association's annual meeting, 71st Scientific Session, this June in San Diego. Dr. Bonventre was featured at a symposium entitled "New Concepts in Diagnosing and Treating Diabetic Nephropathy...
  2011-07-05
Linagliptin In Combination With Metformin And A Sulphonylurea Demonstrates Significant Efficacy And Favourable Tolerability In Type 2 Diabetes
  • Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced Phase III study results for linagliptin (proposed European trade name, Trajenta®) presented at the 71st American Diabetes Association Scientific Meeting, demonstrating improved glycaemic control in adults with type 2 diabetes (T2D) whose blood glucose is not adequately controlled on existing treatment...
  2011-07-04
Fluorescent Fish Could Hold The Key To Understanding Diabetes And Other Diseases
  • Scientists from Queen Mary, University of London have discovered a new way of detecting zinc in zebra fish, that could pave the way for furthering our understanding of diseases like type 2 diabetes, prostate cancer and Alzheimer's. The results will be announced today (3 July) at the Sixth International Symposium on Macrocyclic and Supramolecular Chemistry, in Brighton...
  2011-07-03
Bristol Myers Squibb And AstraZeneca Announce Investigational Compound DAPAGLIFLOZIN Sustained Glycemic Control And Weight Reduction
  • Bristol-Myers Squibb Company and AstraZeneca announced on June 25th results from an exploratory 78-week study extension of a Phase 3 clinical study that showed the investigational compound dapagliflozin plus metformin sustained greater mean reductions from baseline in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) in patients with type 2 diabetes inadequately con...
  2011-07-02
Preventing Diabetes Damage; Zinc's Effects On A Kinky, Two-Faced Cohort
  • In type 2 diabetes, a protein called amylin forms dense clumps that shut down insulin-producing cells, wreaking havoc on the control of blood sugar. But zinc has a knack for preventing amylin from misbehaving. Recent research at the University of Michigan offers new details about how zinc performs this "security guard" function...
  2011-07-02
Zinc Prevents Diabetes Damage
  • In type 2 diabetes, a protein called amylin forms dense clumps that shut down insulin-producing cells, wreaking havoc on the control of blood sugar. But zinc has a knack for preventing amylin from misbehaving. Recent research at the University of Michigan offers new details about how zinc performs this "security guard" function...
  2011-07-01
Your Guide To Active Summer Living: Success Stories And Tips From Diabetes Forecast
  • Summer is a time for fun and exercise -- for people of all ages and backgrounds. The July issue of Diabetes Forecast, the consumer magazine of the American Diabetes Association, looks at the importance of exercise for people with diabetes and some of their successes, from a professional golfer to young athletes to older folks who are aging gracefully by staying physically active...
  2011-07-01
American Diabetes Association Advising On The Use Of Information Technology To Improve Diabetes Prevention, Management In Beacon Communities
  • The American Diabetes Association and the Centers for Disease Control and Prevention (CDC) are working with the Office of the National Coordinator for Health Information Technology (ONC) in an effort to inform a nationwide program to increase the use of health information technology (IT)...
  2011-06-30
Late Breaking Data Presented At The American Diabetes Association 71st Annual Scientific Sessions Evaluate The Safety And Tolerability Of TAK-875
  • Takeda Pharmaceutical Company Limited (Takeda) announced that results from late breaking data presented by Takeda Global Research & Development Center, Inc...
  2011-06-29
FDA-Approved Diabetes Simulator Commercially Available
  • A computer-based diabetes simulation tool developed by University of Virginia researchers is now commercially available, thanks to a partnership with the Charlottesville-based medical research firm The Epsilon Group. The simulator is the only protocol that has been accepted by the U.S. Food and Drug Administration as an alternative to animal testing of Type 1 diabetes control strategies...
  2011-06-29
The Lancet Publishes Data From Protege, MacroGenics' Phase 3 Clinical Study Of Teplizumab In Type 1 Diabetes Patients
  • MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of results from Protege, a Phase 3 clinical study of teplizumab in type 1 diabetes...
  2011-06-29
ChemoCentryx Reports CCX140, A Novel Oral CCR2 Antagonist, Demonstrates Clinical Activity On Glycemic Indices In A Phase II Study In Type 2 Diabetes
  • ChemoCentryx, Inc. announced that CCX140, the Company's novel, orally active CCR2 antagonist successfully met its primary endpoint of safety and tolerability and demonstrated clinical efficacy in a Phase II study in patients with type 2 diabetes on stable doses of metformin...
  2011-06-29
Dapagliflozin Added To Metformin Sustained Reductions In Blood Sugar Levels In Adult Patients With Type 2 Diabetes
  • Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a long-term (104 weeks) Phase 3 clinical study which showed that the investigational compound dapagliflozin added to metformin sustained reductions of blood sugar levels (glycosylated hemoglobin levels, or HbA1c) from 52-weeks to 104-weeks, in adults with type 2 diabetes when compa...
  2011-06-28
Flavonoids Could Represent Two-Fisted Assault On Diabetic Complications And Nervous System Disorders
  • CA-A recent study from scientists at the Salk Institute for Biological Studies suggests that a strawberry a day (or more accurately, 37 of them) could keep not just one doctor away, but an entire fleet of them, including the neurologist, the endocrinologist, and maybe even the oncologist...
  2011-06-28
Nutritional Management With Medical Food Alleviates Diabetes-Induced Large And Small Fiber Neuropathies
  • Results from a study which evaluated Metanx® on diabetic peripheral neuropathy using Zucker diabetic fatty (ZDF) rats, a model of Type 2 diabetes, were presented at the American Diabetes Association 71st Scientific Sessions. Diabetes disrupts the natural metabolic processes in both blood vessel and peripheral nerve tissues which often leads to progressive symptomatic diabetic neuropathy...
  2011-06-28
Studies Show No Increased Risk Of Cardiac Events In Diabetes Patients Treated With AFREZZA(R)
  • The findings of two separate studies further substantiate that treatment with the investigational ultra rapid acting mealtime insulin AFREZZA® (insulin human [rDNA origin]) Inhalation Powder does not result in excess cardiovascular events in type 1 or type 2 diabetes patients...
  2011-06-28
New Data Shows Victoza(R) Helped Reduce Blood Sugar When Patients With Type 2 Diabetes Switched From Sitagliptin Or Exenatide
  • Novo Nordisk will present data from two extension studies at the 71st Annual Scientific Sessions of the American Diabetes Association (ADA) which show that Victoza® (liraglutide [rDNA origin] injection), taken once-daily, in combination with metformin and/or sulfonylurea, helped patients achieve blood sugar control after switching from other commonly used type 2 diabetes therapies...
  2011-06-27
Data Show That A Decrease In Tethys' PreDx(R) Diabetes Risk Score (DRS) Is Correlated With Lowered Risk Of Diabetes
  • Data presented today from an analysis of samples from the European Diabetes Prevention Study (EDIPS) showed that the PreDx® Diabetes Risk Score (DRS) is lowered by lifestyle intervention, which correlates to a reduction in the risk that patients will develop diabetes over time...
  2011-06-27
Structure House Presents Data Correlating Weight Loss, Reduction Of Diabetes Risk Factors And Lowering Of Tethys' PreDx(R) Diabetes Risk Score
  • Structure House, an internationally recognized residential weight loss center, today presented data from a research study of obese individuals in a residential weight loss program showing a correlation among degree of weight loss, reduced cardiometabolic risk factors including cholesterol, triglycerides, and blood pressure, and lowered PreDx® Diabetes Risk Score (DRS)...
  2011-06-27
Global Diabetes Population Rises From 150 To 350 Million In 30 Years
  • The number of people with diabetes worldwide is estimated to have risen by about 133% to approximately 350 million, researchers from Imperial College London and Harvard School of Public Health report in the medical journal The Lancet. The authors explain that the main reason for this rise has been longer life spans - people today live longer and diabetes risk increases with age...
  2011-06-26
Generic Drug Reproduces Mechanism That Reversed Diabetes In Mice, Phase II Trial Now Underway
  • Promising results of the Phase I clinical trial of the generic drug BCG (bacillus Calmette-Guerin) to treat advanced type I diabetes were announced today at the American Diabetes Association scientific sessions in San Diego. A research team led by Denise Faustman, MD, PhD, director of the Massachusetts General Hospital (MGH) Immunobiology Laboratory is presenting two abstracts (No. 2240-PO and No...
  2011-06-26
In A New Post-hoc Analysis, Significantly More Patients Achieved Blood Sugar Goals With JANUMET
  • In a new post-hoc analysis based on the American Association of Clinical Endocrinologists (AACE/ACE) diabetes algorithm presented at the American Diabetes Association (ADA) 71st Annual Scientific Sessions, significantly more patients with type 2 diabetes treated with JANUMET® (sitagliptin/metformin HCl) tablets achieved blood sugar goals after 18 weeks compared to metformin as initial therapy...
  2011-06-26
Safer And More Effective Diabetes Control With Basal Insulin Analogs
  • Basal insulin analogs have revolutionized diabetes care, and especially the treatment of type 2 diabetes, enabling patients to achieve better control of blood glucose levels while reducing hypoglycemic episodes...
  2011-06-26
Type 1 Diabetes Patients Using AFREZZA Have More Positive View Of Therapy Compared To Standard Insulin Therapy
  • Results of a new patient-reported outcomes (PRO) study show that patients with type 1 diabetes who received the investigational ultra rapid acting mealtime insulin, AFREZZA® (insulin human [rDNA origin]) Inhalation Powder, combined with basal insulin, came to view insulin therapy more positively during the course of a 16-week study compared with patients using standard ther...
  2011-06-26
Mayo Clinic Developing Artificial Pancreas To Ease Diabetes Burden
  • The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible. As part of this effort, Drs...
  2011-06-25
Cebix's Long-Acting C-Peptide Ersatta™ Has Potential In Multiple Chronic Complications Of Diabetes
  • Cebix Incorporated announced that preclinical data for its long-acting form of C-peptide, Ersatta™ (CBX129801), demonstrated a half-life of three days as compared to one hour for native C-peptide. Ersatta halted the impairment in nerve conduction velocity, a measure of the rate at which electrical signals travel through the nerves, in an animal model of diabetic peripheral neuropathy...
  2011-06-25
Linagliptin Recommended For Approval In The Treatment Of Type 2 Diabetes In Europe
  • Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Tradjenta® in Europe) for the treatment of adults with type 2 diabetes...
  2011-06-25
Health Economics Model Shows That Dermagraft® Combined With Conventional Care Is A Cost-Effective Treatment For Diabetic Foot Ulcers In Medicare
  • Advanced BioHealing, Inc...
  2011-06-25
Analysis Shows BYDUREON™ Was Not Associated With Clinically Relevant QT Prolongation In Patients With Type 2 Diabetes
  • Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced results from an analysis of the DURATION-1 study that showed the investigational type 2 diabetes medication BYDUREON™ (exenatide extended-release for injectable suspension) was not associated with clinically relevant QT prolongation in patients with type 2 diabetes...
  2011-06-25
Analysis Provides New Insights Into Use Of SYMLIN® In Patients With Type 1 Diabetes Using Insulin Pumps
  • Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced data from a new analysis characterizing the effects of SYMLIN® (pramlintide acetate) injection in patients with type 1 diabetes who used insulin pumps during two previously completed clinical studies...
  2011-06-25
Dog Consumed Part Of A Sleeping Patient's Toe: Case Study To Highlight The Danger Of Pets In The Presence Of Open Wounds
  • In a case study that illustrates the need for people with diabetes to be cautious of foot injuries and to protect themselves from pets, a woman with numbness in her feet caused by diabetic neuropathy slept through a traumatic episode in which her Jack Russell terrier chewed off part of her slightly infected big toe, according to an article published in this month's issue of the...
  2011-06-24
New Discoveries In Diabetes
  • A new signal pathway that renders the insulin-releasing beta cell more sensitive to high levels of blood glucose has been discovered by researchers at the Swedish medical university Karolinska Institutet. A second new study reveals a possible way to delay the disease by inhibiting a lipoprotein...
  2011-06-24
Fewer Primary-Care Physicians Refer All Patients With Diabetes To Diabetes Education Programs
  • While studies have shown that diabetes education programs are crucial in helping individuals living with the disease self-manage their condition, a new study led by Ryerson researchers has found that less than half of primary-care physicians surveyed refer all of their patients with diabetes to these programs...
  2011-06-24
Advocates, 150 Children With Type 1 Diabetes Urge FDA To Enable Critical Research On Life-Saving Artificial Pancreas To Move Forward
  • Kevin Kline and four children with type 1 diabetes urged the Food and Drug Administration (FDA) to take immediate action to accelerate the research and review of artificial pancreas systems at a hearing before the Senate Committee on Homeland Security and Government Affairs...
  2011-06-23
Still Hope For GAD Diabetes Vaccine
  • Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children are vaccinated, is continuing as planned, and now with more money behind it. "I am still hopeful that the GAD vaccine will work", says Helena Elding Larsson...
  2011-06-23
Dietary Leucine May Fight Prediabetes, Metabolic Syndrome
  • A study led by researchers at the Joslin Diabetes Center suggests that adding the amino acid leucine to their diets may help those with pre-diabetes or metabolic syndrome...
  2011-06-23
Amylin Pharmaceuticals To Present Promising New Data On The Company's Diabetes Programs At ADA 2011
  • Amylin Pharmaceuticals, Inc...
  2011-06-21
Advocates, Children With Type 1 Diabetes Testify In Senate Hearing For JDRF's Children's Congress 2011
  • On Wednesday, actor Kevin Kline and children with type 1 diabetes from all over the country will testify before the Senate Committee on Homeland Security and Government Affairs to thank Congress for its renewal last December of the Special Diabetes Program and highlight the importance of the federal government's commitment in helping to advance type 1 diabetes research...
  2011-06-21
New Data Confirm Superior Blood Pressure Reductions In Diabetic Patients Treated With TWYNSTA® Compared To Amlodipine Alone
  • New data show that TWYNSTA® , a once daily, single pill combination of the angiotensin II receptor blocker (ARB) telmisartan and the calcium channel blocker (CCB) amlodipine, leads to prompt and very effective reductions in blood pressure in hypertensive patients with diabetes...
  2011-06-18
Medical Societies Respond To The FDA's Safety Announcement On The Use Of The Diabetes Medication Actos (Pioglitazone)
  • Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer...
  2011-06-17
Cebix Initiates Phase 1b Clinical Trial With Drug Candidate Ersatta™
  • Cebix Incorporated announced it is advancing the development of modified C-peptide for the treatment of complications of diabetes. The biopharmaceutical company has initiated a Phase 1b clinical trial to evaluate Ersatta™, its proprietary long-acting form of C-peptide, in patients with type 1 diabetes who, because of their disease, lack this endogenous peptide...
  2011-06-17
Type 2 Diabetes Decision Support Tool Available
  • A new computerised prescribing decision support tool designed to assist in the implementation of NICE guidance1,2 for the management of type 2 diabetes in adults in primary care is now available free to UK healthcare professionals...
  2011-06-16
Takeda Responds To U.S. Food And Drug Administration Update To Safety Review Of ACTOS (pioglitazone HCl)
  • Following an announcement from the U.S. Food and Drug Administration (FDA) regarding an update to its safety review of ACTOS, Takeda Pharmaceuticals North America, Inc. (Takeda) is confident in the therapeutic benefits of ACTOS and its importance as a treatment for type 2 diabetes...
  2011-06-16
Poor Management Of Diabetes Is Costing The NHS Up To £20 Million
  • HIGH WYCOMBE, Emergency hospital admissions for hypoglycaemia ('hypo'), a condition affecting people with diabetes, have risen by 13% in the last recorded year, with an increase of 76% in the last five years, costing an average of £892 with each admission.1 'Hypos' were also found to be responsible for 67,000 bed days in a single year costing the NHS up to £20 million...
  2011-06-14
By Keeping Diabetes Secret, One Million People In The UK Risk Their Health
  • Nearly one million people1 in the UK could be risking their health and experiencing emotional distress by keeping their diabetes a secret according to a survey by leading health charity Diabetes UK. The survey2, conducted for Diabetes Week (12 - 18 June 2011), found that one in three people with diabetes (34 per cent) had, or were still, keeping their diabetes a secret...
  2011-06-13
Research Team Tests Alternative Approach To Treating Diabetes
  • In a mouse study, scientists at Mayo Clinic Florida have demonstrated the feasibility of a promising new strategy for treating human type 2 diabetes, which affects more than 200 million people worldwide. In type 2 diabetes, the body stops responding efficiently to insulin, a hormone that controls blood sugar...
  2011-06-10
Profil Institute And Rosa Announce Strategic Partnership Offering Newest Simulation Technology To Enhance Diabetes And Obesity Clinical Trials
  • Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co...
  2011-06-09
FDA Approves Updates To Lilly's Humalog® (insulin Lispro Injection [rDNA Origin]) Label
  • Eli Lilly and Company (NYSE: LLY) announced that the U.S...
  2011-06-09
Teens With Type 2 Diabetes Already Show Possible Signs Of Impaired Heart Function
  • Heart function may be affected in people with Type 2 diabetes as early as adolescence, according to a new study that will be presented Sunday at The Endocrine Society's 93rd Annual Meeting in Boston. "Past studies in adults with Type 2 diabetes show that their heart and blood vessels' ability to adapt to exercise may be impaired...
  2011-06-08
Understanding Glycemic Control In The Critically Ill: 2011 Update
  • Intensive monitoring of blood glucose concentrations in critically ill patients has become a standard of care in intensive care units over the past 10 years...
  2011-06-07
Hyperglycemia Is Associated With Increased Hospital Complications And Mortality During Parental Nutrition
  • Malnutrition in critically ill patients can lead to many negative effects, such as an increased risk of hospital complications, higher mortality rate, longer length of hospital stay, and higher resource utilization. Parental nutrition (PN) creates a well-documented positive change in critically ill patients' nutritional status and helps to prevent many of these negative side effects...
  2011-06-07
New Weapons In The Fight Against Juvenile Diabetes
  • Engineering researchers at Rensselaer Polytechnic Institute are combining automation techniques from oil refining and other diverse areas to help create a closed-loop artificial pancreas. The device will automatically monitor blood sugar levels and administer insulin to patients with Type 1 diabetes, and aims to remove much of the guesswork for those living with the chronic disease...
  2011-06-07
Dual Isotope SPECT/CT Reduces Amputations In Diabetic Patients
  • Research introduced at SNM's 58th Annual Meeting reveals the extent to which an ongoing study can help save life and limb for patients with diabetes-related foot infections. Diabetes can cause nerve damage and reduced blood flow to the bones and tissues of the feet, leaving diabetics vulnerable to infection...
  2011-06-07
Women's Risk Of Heart Disease After Gestational Diabetes Differs By Race
  • New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston...
  2011-06-06
One In Five People With Diabetes Miss Up To 15 Working Hours Per Month Due To Low Blood Sugar
  • Nearly one in five people with diabetes are regularly unable to attend a full day at work due to disruption caused by episodes of dangerously low blood sugar, known as a hypoglycaemic event.1 A new survey, focusing on productivity loss following hypoglycaemic events, was published today in the journal Value in Health...
  2011-06-06
New Treatment Hope For Diabetes And Cardiovascular Diseases
  • New research at the University of Leicester to contribute to more effective drug design. A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases...
  2011-06-04
Animas(R) Vibe™, The First Integrated Offering From Animas Corporation And Dexcom, Inc., Receives European CE Mark Approval
  • Animas Corporation announced today the receipt of CE Mark approval for Animas® Vibe™, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology...
  2011-06-03
Type 1 Diabetics Have A Fat-Burning Advantage
  • Researchers may have discovered a new advantage for Type 1 diabetics, according to research presented today at the American College of Sports Medicine's (ACSM) 58th Annual Meeting and 2nd World Congress on Exercise is Medicine®. New research suggests that diabetics may burn more fat than non-diabetics during exercise...
  2011-06-02
New Research Urges Diabetics To Find The Light
  • Spending time in a brightly lit room after a meal may help Type 2 diabetics regulate their blood sugar levels, according to research being presented today at the 58th Annual Meeting of the American College of Sports Medicine and 2nd World Congress on Exercise is Medicine®. In this study, Arnold Nelson, Ph.D...
  2011-06-02
Pre-Diabetic? Start Eating More Fruit
  • Before people develop type 2 diabetes, they almost always have "prediabetes," defined as blood glucose levels that are higher than normal but not yet high enough to be diagnosed as diabetes. There are 79 million people in the United States who have prediabetes. Recent research has shown that even during prediabetes both heart and circulatory long-term damage to the body may already be occurring...
  2011-06-01
Diamyd Medical: Diamyd Closes European Phase III Study
  • Diamyd Medical AB (STO:DIAMB)(Pink Sheets:DMYDY) reports that the Company has decided not to complete the follow-up period of a European Phase III study with the antigen-based therapy Diamyd®...
  2011-06-01
Diamyd Medical: Diamyd Regains Control Of Diabetes Therapy
  • Diamyd Medical AB (STO:DIAMB)(Pink Sheets:DMYDY) announces it has regained control of the diabetes therapy Diamyd® following Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) election to terminate the agreement the two companies signed in June 2010 to develop and commercialize Diamyd®. In June 2010, Diamyd Medical AB and Ortho-McNeil-Janssen Pharmaceuticals, Inc...
  2011-06-01
Fracture Prediction Methods May Be Useful For Patients With Diabetes
  • Use of established fracture prediction methods in older patients with type 2 diabetes mellitus (DM) found that scores from these methods were associated with hip and nonspine fracture risk, and a certain score associated with higher risk of fracture compared to persons without DM, according to a study in the June 1 issue of JAMA...
  2011-05-31
HbA1C Test For Glucose Monitoring Poorly Predictive In Dialysis Patients
  • The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center. The study appears online in the Clinical Journal of the American Society of Nephrology and is scheduled for the July print issue. Blood sugar monitoring is a vital part of diabetes management...
  2011-05-31
Pregnancy Diabetes Risk Can Be Predicted Up To Seven Years Before
  • The risk of developing diabetes in pregnancy can be predicted up to seven years before by carefully monitoring known risk factors associated with diabetes and heart risk said researchers in California whose findings are published online today in the American Journal of Obstetrics and Gynecology...
  2011-05-30
Einstein Addresses Bronx Diabetes Epidemic In Community Health Program
  • Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease an alarming 11 percent of the population. The condition has been renamed type 2 diabetes because nearly a quarter of a million children also have it...
  2011-05-27
Ongoing Trial Testing Lecithin Component For Reducing Fatty Liver, Improving Insulin Sensitivity
  • A natural product called DLPC (dilauroyl phosphatidylcholine) increases sensitivity to insulin and reduces fatty liver in mice, leading Baylor College of Medicine researchers to believe it may provide a treatment for prediabetic patients. DLPC is an unusual phospholipid and a trace component of the dietary supplement lecithin. Dr. David D...
  2011-05-26
HealthPartners Personalizing Medicine For Diabetes Patients
  • Patients with diabetes and their physicians will soon have access to a new decision support tool that will reliably support a highly customized and state-of-the-art treatment plan in HealthPartners clinics. "The electronic medical record can present personalized patient information in a single screen to the physician and patient in an instant...
  2011-05-25
Derma Sciences Reports Continued Healing At 24 Weeks In Patients With Diabetic Foot Ulcers Treated With DSC127 In Phase 2 Trial
  • Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic (0...
  2011-05-25
News From The Journal Of Clinical Investigation: May 23, 2011
  • NEPHROLOGY: Complex inhibition of severe complication of diabetes Diabetic nephropathy is a serious, sometimes lethal, complication of diabetes (both type 1 and type 2 diabetes). The prevalence of this devastating progressive kidney disease, which often leads to the need for dialysis or kidney transplantation, is increasing, making it a major public health problem in modern society...
  2011-05-24
CT Scan Could Help Predict Early Death In Diabetes, Study Shows
  • New findings out of Wake Forest Baptist Medical Center reveal that a common test may be useful in predicting early death in individuals with diabetes. The study appears in the May issue of Diabetes Care. "People with diabetes are already at high risk of developing heart disease and experiencing an early death," said Donald W. Bowden, Ph.D...
  2011-05-23
Lowering Fat Intake Might Stave Off Diabetes Even Without Weight Loss
  • Small differences in diet even without weight loss can significantly affect risk for diabetes, according to research from the University of Alabama at Birmingham published online May 18, 2011, by the American Journal of Clinical Nutrition...
  2011-05-21
Lowering Fat Intake Might Stave Off Diabetes Even Without Weight Loss
  • Small differences in diet - even without weight loss - can significantly affect risk for diabetes, according to research from the University of Alabama at Birmingham published online May 18, 2011, by the American Journal of Clinical Nutrition...
  2011-05-20
Ford Motors To Provide SYNC Diabetes, Allergy Monitoring In Motor Vehicles
  • Call me crazy, but Detroit is going incredibly health conscious and has begun developing technology that will be able to monitor glucose levels, provide severe allergy alerts and keep medical records available all at the touch of a button in your car's interior. Ford Motor Company and their SYNC technology are leading the way...
  2011-05-19
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance In Diabetic Patients With Heart Disease
  • For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), provided remarkably safe and effective outcomes, according to the results of several studies presented today at EuroPCR, a major international meeting for cardiac and vascular specialists...
  2011-05-18
Cell Signaling Networks Tied To Diabetes And Cancer
  • Researchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological processes involved in major diseases such as diabetes and cancer. This work could help scientists design drugs to battle these disorders...
  2011-05-18
Vildagliptin(TM) More Effective In Type 2 Diabetes Management During Fasting Than The Most Commonly Prescribed Treatment
  • Data published today in Current Medical Research and Opinion show that Vildagliptin(TM) (a DPP-4 inhibitor) with metformin significantly reduces the incidence of hypoglycaemia, compared to the most commonly prescribed treatment combination, a sulphonylurea (SU) with metformin1...
  2011-05-18
News From The Journal Of Clinical Investigation: May 16, 2011
  • TECHNICAL ADVANCE: Mosaics model degenerative disease Degenerative disorders such as type 1 diabetes and Parkinson disease result from the gradual loss of a particular cell type. The conditions are only diagnosed after cell loss reaches such a level that symptoms are detectable; for example, approximately 80% of pancreatic beta-cells are lost before symptoms of type 1 diabetes arise...
  2011-05-17
New Mouse Model Provides A Way To Study Degenerative Diseases
  • Most degenerative diseases begin with a gradual loss of specific cell types that progresses, eventually leading to symptoms...
  2011-05-17
News From Annals Of Internal Medicine: May 17, 2011
  • 1...
  2011-05-17
Tale Of Two Mice Pinpoints Major Factor For Insulin Resistance
  • The road to type 2 diabetes is paved with insulin resistance, a condition often associated with obesity in which the hormone begins to fail at its job helping to convert sugars to energy. Researchers at Joslin Diabetes Center have now identified an enzyme called PKC-delta as an important molecular modifier for development of insulin resistance, diabetes and fatty liver in mice...
  2011-05-16
Pharmacies To Offer Assessments To Help Find The One In 50 People With Undiagnosed Diabetes In Wales
  • Every pharmacy in Wales will offer free Type 2 diabetes risk assessments for a fortnight in a bid to find the 66,000 people thought to have undiagnosed diabetes. From Monday 13 June, which falls during Diabetes Week, every Welsh pharmacy will offer simple paper-based assessments to identify people at risk of developing the condition in the next 10 years...
  2011-05-15
Discovery Of 'Master Switch' Gene For Obesity And Diabetes
  • A team of researchers, led by King's College London and the University of Oxford, have found that a gene linked to type 2 diabetes and cholesterol levels is in fact a 'master regulator' gene, which controls the behaviour of other genes found within fat in the body...
  2011-05-15
TPI Receives SFDA Approval For Its Anti-Diabetic Drug Gliclazide
  • Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced that TPI has received the China's SFDA's approval for its anti-diabetic drug Gliclazide Tablets (80 mg formulation)...
  2011-05-14
HDAC Inhibitors May Provide A Novel Way To Cut Excessive Blood Glucose Levels At The Source
  • A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease...
  2011-05-13
Animas And LifeScan Strengthen Strategic Focus To Better Serve People Living With Diabetes
  • Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for people living with diabetes...
  2011-05-12
The Sanford Project & DiaMedica Announces Successful Type 1 Diabetes NOD Mouse Study With DM-199
  • The Sanford Project & DiaMedica (TSX-V:DMA) today announce the successful completion of a study involving DM-199 in preventing the onset of Type 1 diabetes in the non-obese diabetic (NOD) mouse model...
  2011-05-11
Medtronic And Bayer Healthcare Expand International Alliance
  • Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients worldwide...
  2011-05-10
Metabolic Disease And Diabetes
  • Humans with rare genetic mutation point diabetes researchers in the right direction The cells in the body of an individual with type 2 diabetes are resistant to the effects of the hormone insulin. A few individuals are born resistant to the effects of insulin as a result of mutations in their INSR gene, which templates the protein via which insulin mediates its effects...
  2011-05-10
NICE Publishes New Guidance On Preventing Type 2 Diabetes
  • NICE has today (Tuesday 10 May) published new guidance on preventing type 2 diabetes in the general population, and among high-risk groups. These groups include people of South Asian, African-Caribbean, black African and Chinese descent, and those from a lower socio-economic background, where the incidence of type 2 diabetes is higher than in the general population...
  2011-05-10
Diabetes Levels In Canadian Inuit Similar To Those In General Population
  • Canadian Inuit are not protected from the health consequences of obesity, contrary to previous knowledge, and their diabetes levels are similar to those in the general population, according to an article in CMAJ (Canadian Medical Association Journal)...
  2011-05-09
Study Demonstrates Benefits Of MicroPulse™ Photocoagulation Over Current Standard Laser Treatment Of Diabetic Macular Edema
  • IRIDEX Corporation (Nasdaq: IRIX) announced that leading clinicians have performed and published the results of a new study* that compares the benefits of MicroPulse photocoagulation technology, similar to that used in the new generation IRIDEX lasers, over the standard-of-care protocol for the treatment of eyes with diabetic macular edema (DME)...
  2011-05-05
Structured Exercise Helps Diabetics Control Blood Sugar
  • Structured exercise programs comprising aerobics, resistance training or both helps people with type 2 diabetes control blood sugar levels, and although physical exercise advice by itself does not appear to make any difference, when combined with dietary advice it does, according to a Brazilian-led study that pooled data from over 50 trials involving more than 8,500 participants...
  2011-05-04
Cardiovascular Side Effects Of Popular Diabetes Drugs Explained
  • Drugs known as thiazolidinediones, or TZDs for short, are widely used in diabetes treatment, but they come with a downside. The drugs have effects on the kidneys that lead to fluid retention as the volume of plasma in the bloodstream expands. "TZDs usually increase body weight by several kilograms," said George Seki of the University of Tokyo...
  2011-05-04
2011 BIO International Convention To Host New Forum On Diabetes
  • In an effort to raise awareness for one of the most costly chronic diseases facing adults and children, the Biotechnology Industry Organization (BIO), together with the Juvenile Diabetes Research Foundation (JDRF), will feature a two-day diabetes forum for the first time at its 2011 BIO International Convention. The Convention will take place June 27-30, 2011, in Washington, D.C. at the Walter E...
  2011-05-04
FDA Approves New Treatment For Type 2 Diabetes
  • The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose control in adults with Type 2 diabetes. People with Type 2 diabetes do not produce or respond normally to insulin, a hormone that regulates the amount of glucose in the blood...
  2011-05-03
Insomnia Linked To High Insulin Resistance In Diabetics
  • In the largest study of it kind to establish a link between sleep and diabetes, researchers found that people with diabetes who sleep poorly have higher insulin resistance, and a harder time controlling the disease. The findings, published in the June issue of Diabetes Care, suggest that poor sleep may contribute to worse outcomes in people with diabetes...
  2011-05-03
Children's Mercy Researchers Find Two Tests Are Better Than One At Diagnosing Diabetes In Overweight Children
  • A new study found that the recommended blood test may not be enough to catch type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition...
  2011-05-03
System In Brain - Target Of Class Of Diabetes Drugs - Linked To Weight Gain
  • University of Cincinnati (UC) researchers have determined why a certain class of diabetes drugs leads to weight gain and have found that the molecular system involved (PPAR-γ found in the brain) is also triggered by consumption of high-fat foods...
  2011-05-02
D. Medical Subsidiary, Spring-Set Health Solutions Ltd., Receives FDA 510(k) Clearance To Market Its Spring Universal Infusion Sets In U.S.
  • D. Medical Industries Ltd. (NASDAQ:DMED)(TASE:DMED) ("D. Medical" or the "Company"), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, has announced that the U.S. Food and Drug Administration ("FDA") has granted its subsidiary, Spring-Set Health Solutions Ltd...
  2011-05-02
Christos Mantzoros Honored By Federation Of The American Societies For Experimental Biology
  • Christos Mantzoros, MD, DSc, Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center (BIDMC), delivered the Solomon A. Berson Distinguished Lectureship at the annual meeting of the Federation of American Societies for Experimental Biology (FASEB) held in Washington, DC. Named in honor of Dr. Solomon A...
  2011-05-01
Researchers Discover Way To Make Insulin Cells
  • Simply put, people develop diabetes because they don't have enough pancreatic beta cells to produce the insulin necessary to regulate their blood sugar levels. But what if other cells in the body could be coaxed into becoming pancreatic beta cells? Could we potentially cure diabetes? Researchers from UCLA's Larry L...
  2011-04-30
For Glucose Control Bariatric Surgery Better Than Dieting
  • Researchers at Duke University Medical Center and St. Luke's and Roosevelt Hospital Center, Columbia University, have uncovered a new clue for why bariatric surgery is more effective than dietary remedies alone at controlling glucose levels...
  2011-04-28
Medical Costs For Youth With Diabetes More Than $9,000 A Year
  • Young people with diabetes face substantially higher medical costs than children and teens without the disease, according to a CDC study published in the May issue of the journal Diabetes Care. The study found annual medical expenses for youth with diabetes are $9,061, compared to $1,468 for youth without the disease...
  2011-04-28
UN Summit Decision Marks Outstanding Year For Diabetes
  • The International Diabetes Federation (IDF), representing over 200 diabetes associations in 160 countries, today released its first ever Annual Report 2010, replacing its usual triennial activity report...
  2011-04-27
Early Warning That A Child Will Develop Diabetes May Be Possible By Monitoring Protein Levels
  • Decreasing blood levels of a protein that helps control inflammation may be a red flag that could help children avoid type 1 diabetes, researchers say. Georgia Health Sciences University researchers are looking at blood levels of interleukin-1 receptor antagonist, or IL-1ra, in children being closely followed because their genes put them at risk for type 1 diabetes...
  2011-04-25
PVT1 Is Associated With Proteins Responsible For Reduced Blood Filtration: Findings Contribute To Understanding Of Diabetic Kidney Disease
  • A gene called PVT1 may help reduce the kidneys ability to filter blood, leading to kidney disease, kidney failure and death, according to a study published by researchers at the Translational Genomics Research Institute (TGen). The TGen team found PVT1 expression levels increased up to 5-fold in response to hyperglycemia, or high blood sugar, a condition that often accompanies diabetes...
  2011-04-24
Diabetes May Be Driven By Subset Of Self-Destructive Immune Cells
  • New research identifies a distinctive population of immune cells that may play a key role in the pathogenesis of diabetes...
  2011-04-22
American Diabetes Association Launches Program To Support People Newly Diagnosed With Type 2 Diabetes
  • Today more than 5200 people will be diagnosed with diabetes -- the majority of them with type 2 diabetes. A new American Diabetes Association initiative called the Living With Type 2 Diabetes Program was launched today to support those newly diagnosed with type 2 diabetes. People can enroll in this free program by visiting http://www.diabetes.org/living or calling 1-800-DIABETES...
  2011-04-21
Low Carbohydrate Diet May Reverse Kidney Damage In Diabetes
  • Researchers from Mount Sinai School of Medicine have for the first time determined that the ketogenic diet, a specialized high-fat, low carbohydrate diet, may reverse impaired kidney function in Type 1 and Type 2 diabetes. They also identified a previously unreported panel of genes associated with diabetes-related kidney damage, whose changes in expression were reversed by the diet...
  2011-04-20
Diabetes And Prediabetes Are On The Rise: New Medication In Research Trials
  • As the newest statistics from the CDC show, diabetes is an ever increasing problem for Americans. Almost 26 million adults in this country now have diabetes, an increase of 9% since 2008. Ninety to 95% of cases are type 2 diabetes, marked by a gradual inability of the body's cells to respond to insulin, and eventually an inability to produce enough insulin...
  2011-04-20
DiaMedica's Type 2 Diabetes Antibody Shown To Increase Glucose Infusion Rate By 291%
  • DiaMedica (TSX-V:DMA) today announces positive and important activity with DM-204, its lead monoclonal antibody. In a gold-standard animal model for testing Type 2 diabetes therapies, administration of DM-204 caused a significant increase in glucose utilization...
  2011-04-20
'Diabetes: Focus On Women' Provides A Practical Approach For All Women With Diabetes
  • "If there is anything that this disease has done to improve my life, it taught me at a young age how to take care of myself." - Nikki Peterson, 24 years old, diabetes for 14 years. Like Nikki, women with diabetes must adapt to their unique, individual challenges associated with their disease...
  2011-04-20
Is Type 2 Diabetes An Autoimmune Disease?
  • Type 2 diabetes is in the process of being redefined as an autoimmune disease rather than just a metabolic disorder, said an author of a new study published in Nature Medicine this week, the findings of which may lead to new diabetes treatments that target the immune system instead of trying to control blood sugar...
  2011-04-19
Elderly Diabetes Patients With Very Low Glucose Levels Have Slightly Increased Risk Of Death
  • A new study of older diabetes patients has found that well-controlled blood sugar levels were associated with a lower risk of major complications such as heart attacks, amputation and kidney disease, but the very lowest blood sugar levels were associated with a small but significant increased risk of death...
  2011-04-19
Roche Launches EMR Interface For VA To Facilitate Diabetes Management
  • Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has introduced a new Electronic Medical Record (EMR) interface for the U.S. Department of Veterans Affairs (VA) that helps VA healthcare facilities improve their efficiency and accuracy by transmitting patient diabetes management data directly into the VistA computerized patient record system (CPRS)...
  2011-04-19
Bydureon™ Recommended For Approval In Europe
  • Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes, Inc...
  2011-04-18
Health Of Canadians At A Tipping Point - Canadian Diabetes Association
  • The results of an exclusive Canadian Diabetes Association public opinion poll revealed today the serious concern by Canadians that the diabetes epidemic in Canada threatens the health of their own families, the healthcare system and the Canadian economy...
  2011-04-18
Combination Bydureon For Diabetes Gets Positive Opinion In Europe
  • Bydureon has been given a positive opinion by CHMP (the Committee for Medicinal Products for Human Use), part of EMA (the European Medicines Agency) for type 2 diabetes treatment in combination with other medications. The injection is aimed at patients whose glycemic control has not responded well to maximum doses of oral drugs...
  2011-04-16
Cornerstone Health Care, Anceta, And Humedica Present Initiatives Focused On Improving Diabetes Patient Care
  • John Walker, M.D., C.P.E., Chief Medical Officer, Cornerstone Health Care, is presenting Cornerstone's successful use of Humedica MinedShareTM Ambulatory as a basis for its new Patient Care Advocate program. Joining Dr. Walker in the presentation are John Cuddeback, M.D., Ph.D. Chief Medical Informatics Officer, Anceta and A.G. Breitenstein, J.D., M.P.H...
  2011-04-16
Halozyme's Ultrafast Insulin Generates Faster-In And Faster-Out Profile For Type 1 Diabetes Patients Using Insulin Pumps
  • Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced results from a study in type 1 diabetes patients who receive their insulin treatment with a pump demonstrating that Aspart-PH20, a formulation of Halozyme's rHuPH20 (recombinant human hyaluronidase) with the active ingredient in NovoLog®, accelerates insulin absorption and shortened its duration of action...
  2011-04-16
Victoza® Meta-Analysis Shows Greater Blood Sugar Control At All Baseline A1C Levels When Compared To Other Therapies
  • Novo Nordisk presented data that showed regardless of baseline A1C, once-daily Victoza® (liraglutide [rDNA origin] injection) 1.8 mg consistently helped more patients achieve blood sugar control than some other commonly used type 2 diabetes therapies. The data were presented at the 20th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE)...
  2011-04-16
How Can Metabolic Surgery Cure Diabetes So Fast?
  • "Since the recovery from diabetes occurs so early, a process other than weight loss has to be behind it. If we can identify and imitate this process, it could lead to entirely new ways of treating type 2 diabetes", says Nils Wierup, one of the researchers behind the study...
  2011-04-15
Artificial Pancreas May Improve Overnight Control Of Diabetes In Adults
  • Two small randomised trials published on bmj.com today suggest that closed loop insulin delivery (also known as an artificial pancreas) may improve overnight blood glucose control and reduce the risk of nocturnal hypoglycaemia (a sudden drop in blood glucose levels during the night) in adults with type 1 diabetes...
  2011-04-14
Devon Medical Products Receives FDA 510(k) Clearance For ArterioFlow™ Pump That Treats Diabetic Foot, Peripheral Arterial Disorders
  • Devon Medical Products, a manufacturer and distributor of creative, safe, and cost-effective medical devices, today announced it received U.S...
  2011-04-14
AANEM Joint Guideline Documents Scientific Best Practice
  • The American Association of Neuromuscular & and Electrodiagnostic Medicine (AANEM), in collaboration with the American Academy of Neurology (AAN) and the American Academy of Physical Medicine and Rehabilitation (AAPMR), released a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes...
  2011-04-13
Medtronic Launches More Accurate And Comfortable Sensor To Help Improve Glucose Control
  • Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite™ Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 countries outside of the United States...
  2011-04-12
Diabetic Neuropathy Guidelines
  • Many people with diabetes have nerve damage that causes pain, such as burning and tingling in their hands and feet, known as neuropathy. This is a chronic condition that can severely affect a person's quality of life...
  2011-04-12
AAN Issues New Guideline On Best Treatments For Diabetic Nerve Pain
  • The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes...
  2011-04-12
New Diabetes Education Program Yields Improved Blood Sugar Control
  • An intensive program that taught low-income, poorly educated diabetics to better manage their disease resulted in significantly improved long-term blood sugar control, according to Johns Hopkins researchers who designed and implemented the program...
  2011-04-11
'DEAP' In The Heart Of Texas: Diabetes Program Reaching Texans In 12 Counties
  • As of last year, 2.2 million Texans had been diagnosed with diabetes, and, according to estimates by demographers, that figure may increase to as many as 8 million in 2040...
  2011-04-11
Metformin Better And Safer Than Most Other Diabetes Medications
  • Many commonly prescribed medications for patients with diabetes type 2 may be much less effective at preventing cardiovascular disease and death than oral metformin, Danish researchers revealed in the European Heart Journal this week. Diabetes drugs, such as glimepiride, glibenclamide (USA, Canada: glyburide), known as ISs (insulin secretagogues) have been commonly prescribed for many decades...
  2011-04-09
NewCardio Study Shows My3KG Improves Diagnostic Accuracy In Diabetics With Acute Myocardial Infarction
  • NewCardio, Inc...
  2011-04-08
American Diabetes Association Launches Diabetes 24/7
  • The American Diabetes Association is pleased to announce the launch of Diabetes 24/7, a new online application using personal health records that will allow people living with diabetes to manage their condition and share valuable health information with others on their care team...
  2011-04-07
Some Diabetes Drugs Are Better Than Others According To New Study
  • New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin...
  2011-04-06
The Metabolic Signaling Pathway Responsible For Dyslipidemia Identified By Researchers
  • Researchers from Boston University School of Medicine (BUSM), including Yu Li, PhD, and other colleagues, have demonstrated that a nutrient sensing pathway is involved in the disruption of cellular lipid homeostasis in obese and insulin resistant mice fed a diet high in fat and sucrose...
  2011-04-06
AACE Releases New Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan
  • Today the American Association of Clinical Endocrinologists (AACE) released new medical guidelines for developing comprehensive care plan for management of diabetes mellitus. The guidelines are published in Supplement 2 of the March/April 2011 issue of the association's official medical journal, Endocrine Practice (Handelsman Y, et al...
  2011-04-06
Sleeping Difficulties Increase Risk Of Eye Disease In People With Diabetes
  • People with Type 2 diabetes who have obstructive sleep apnoea[1] (OSA) are more at risk of losing their sight due to severe retinopathy[2], as well as foot problems and possible amputation because of neuropathy[3], according to new research...
  2011-04-06
Some Diabetes Drugs Are Better Than Others According To New Study
  • New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin...
  2011-04-06
Structured Diabetes Management Can Significantly Improve Overall Glycaemic Control And Reduce HbA1c Values In Non-insulin Treated Type 2 Diabetes
  • An innovative diabetes management concept including structured self-monitoring of blood glucose (SMBG), data visualisation, pattern analysis and derived therapy adjustments can significantly reduce HbA1c values, improve glycaemic control and enhance patients' quality of life...
  2011-04-05
Reducing Cancer Risk And Mortality By Avoiding Or Controlling Diabetes
  • Results of the NIH-AARP Diet and Health Study revealed that diabetes is associated with lower risk of prostate cancer in men but with higher risk of other cancers in both men and women. The data, to be presented at the AACR 102nd Annual Meeting 2011, held here April 2-6, also showed an association between diabetes and higher cancer mortality rates...
  2011-04-04
News From The Journal Of Clinical Investigation: April 1, 2011
  • METABOLISM New insight into the development of insulin resistance Muscles, liver, and other tissues take up sugar from the blood stream in response to the hormone insulin. Insulin resistance, which is associated with obesity, is a condition in which tissues stop responding to the insulin signal, often leading to diabetes and cardiovascular disease...
  2011-04-03
Age-Related Conditions Develop Faster In Adults With Diabetes
  • Middle-aged adults with diabetes are much more likely to develop age-related conditions than their counterparts who don't have diabetes, according to a new study by the University of Michigan Health System and VA Ann Arbor Healthcare System...
  2011-04-01
Spring Clean Your Diabetes Routine
  • Spring cleaning means it's time to tackle the home, the car, and even the office -- but what about your health? The April issue of Diabetes Forecast, the consumer magazine of the American Diabetes Association, provides spring cleaning advice in five important areas of diabetes care in order to get back to the basics...
  2011-04-01
A Coffee After Fast Food Causes Spike In Blood Sugar Levels
  • Eating a fatty fast food meal is never good for you, but washing that meal down with a coffee is even worse, according to a new University of Guelph study...
  2011-04-01
PREVAIL Initiative Established To Improve Care And Reduce Incidence Of Type 2 Diabetes
  • Tethys Bioscience, Inc. and Duke Clinical Research Institute (DCRI) have established the PREVAIL patient registry, a multi-center, national initiative that will analyze primary care ambulatory practices for risk factor management of patients at high risk of conversion to type 2 diabetes in the US...
  2011-03-31
What Protects Some Against Diabetes Complications?
  • Some people with diabetes possess yet-unidentified factors that reduce the risk for and even prevent them from developing diabetes-related complications, despite living with the disease for decades, a study published in the April issue of Diabetes Care has found...
  2011-03-30
Bariatric Surgery Is Highly Cost-Effective Treatment For Type 2 Diabetes In The Obese
  • Bariatric surgery is an especially cost-effective therapy for managing Type 2 diabetes in moderately and severely obese patients. These findings and others were presented today at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes, hosted by NewYork-Presbyterian Hospital and Weill Cornell Medical College...
  2011-03-30
Diabetes Veterans May Show Ways To Prevent Complications
  • Over time, diabetes can wreak havoc on the body's eyes, cardiovascular system, kidneys and nerves. A major study by Joslin Diabetes Center researchers, however, has found that some people who have survived diabetes for many decades exhibit remarkably few complications a discovery that points toward the presence of protective factors that guard against the disease's effects...
  2011-03-30
Metabolic Solutions Development Company Launches Phase 2a Trial Of Its Second Compound To Treat Type 2 Diabetes
  • Metabolic Solutions Development Company (MSDC), a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes...
  2011-03-30
EndoBarrier Triggers Beneficial Hormone Effects Leading To Rapid Glycemic Control, Weight Loss And Reduced Heart Disease Risk
  • GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, announced today new results from three studies that demonstrate the positive effects of the EndoBarrier®Gastrointestinal Liner on type 2 diabetes, weight loss and other metabolic factors...
  2011-03-30
GW Researchers Receive Grants To Study How Mobile Technology Can Help Patients Manage Diabetes
  • GW researchers have been awarded two grants from the McKesson Foundation as part of its Mobilizing for Health initiative, an initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology. The Mobilizing for Health grants, of up to $250,000 each, will support studies on diabetes care and management...
  2011-03-29
Strong Link Between Nicotine And Diabetes Complications
  • Scientists have reported the first strong evidence implicating nicotine as the main culprit responsible for persistently elevated blood sugar levels - and the resulting increased risk of serious health complications - in people who have diabetes and smoke...
  2011-03-28
Animal Model Study Suggests That Sitagliptin Can Slow The Onset Of Diabetes
  • Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose. Diabetes type 2 does not arise overnight, but slowly progresses for many years as a condition known as prediabetes...
  2011-03-25
Scientists Link DNA "End-Caps" Length To Diabetes Risk New Role For Short Telomeres
  • New evidence has emerged from studies in mice that short telomeres or "caps" at the ends of chromosomes may predispose people to age-related diabetes, according to Johns Hopkins scientists. Telomeres are repetitive sequences of DNA that protect the ends of chromosomes, and they normally shorten with age, much like the caps that protect the end of shoelaces...
  2011-03-25
Oramed Successfully Completes Toxicity Study For ORMD-0801
  • Oramed Pharmaceuticals Inc. (OTC: ORMP), a developer of oral delivery systems, announced today that it has successfully completed a comprehensive toxicity study for its flagship oral insulin capsule, ORMD-0801...
  2011-03-24
Type 2 Diabetes Prevented By Drug In Majority Of High-Risk Individuals: Finding Has Implications For 40 Million Americans
  • A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease, U.S. scientists have reported. The team also noted a 31 percent decrease in the rate of thickening of the carotid artery, the major vessel that supplies blood to the brain...
  2011-03-24
New NICE Guideline On Diabetic Foot Problems Published
  • NICE has today (23 March) published a new guideline for the care of people with diabetic foot problems in hospital. Diabetes is becoming one of the UK's biggest health problems. In 2009, it was estimated that there were 2.3 million people in the UK with type 1 or type 2 diabetes1. With rising numbers of people affected by the condition, the incidence of complications is also on the rise...
  2011-03-23
Siemens Enhances Point-Of-Care HbA1c Analyzer With Added Connectivity And Security Functions
  • Siemens Healthcare Diagnostics announced a new enhanced version of its DCA Vantage Analyzer, a point-of-care (POC) immunoassay analyzer for diabetes management. The system now provides enhanced operator management and connectivity capabilities to meet the growing demands in POC testing for improved compliance management and data capture into patient records...
  2011-03-23
Elevations In 5 Amino Acids May Signal Future Diabetes Risk, Indicate Candidates For Preventive Measures
  • Measuring the levels of small molecules in the blood may be able to identify individuals at elevated risk of developing type 2 diabetes as much as a decade before symptoms of the disorder appear...
  2011-03-21
New American Diabetes Association Guide Offers Guidance For Parents Of Children With Diabetes
  • Diabetes is reaching epidemic proportions in the United States, with nearly 26 million children and adults living with the disease. More than 215,000 children live with type 1 and type 2 diabetes, and 19,200 new cases are being diagnosed each year. Raising a child is a challenging task; however, raising a child with diabetes adds a level of complexity that can be overwhelming for parents...
  2011-03-21
Taking Diabetes Medication Helps Lower Medical Costs, Slightly
  • A new study in the journal Health Services Research shows that diabetes patients who do a better job of taking their medication have slightly lower health care costs. However, "it's not a huge effect," said lead investigator Bruce Stuart, a professor at the University of Maryland School of Pharmacy in Baltimore...
  2011-03-19
In A Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema At 12 Months
  • Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study. This study evaluated the safety and efficacy of PF-04523655 (RTP801I-14) in patients with diabetic macular edema (DME)...
  2011-03-19
Taking Diabetes Medication Helps Lower Medical Costs, Slightly
  • A new study in the journal Health Services Research shows that diabetes patients who do a better job of taking their medication have slightly lower health care costs. However, "it's not a huge effect," said lead investigator Bruce Stuart, a professor at the University of Maryland School of Pharmacy in Baltimore...
  2011-03-18
Study Shows SANUWAVE's Dermapace Is Significantly More Effective Than Hyperbaric Oxygen Therapy In Healing Chronic Diabetic Foot Ulcers
  • SANUWAVE Health, Inc...
  2011-03-18
International Scientific Summit Will Spotlight The Surgical Treatment Of Diabetes And Propose New Directions For Research
  • On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option...
  2011-03-17
How To Overcome Disparities And Reduce The Burden Of Diabetes Complications, Forum, April 6-7, 2011
  • What The American Diabetes Association will convene its Fourth Disparities Partnership Forum to address the severe onset of diabetes and its complications in high-risk populations. The two-day forum will bring together leading experts to discuss community solutions and foster collaborations among various organizations...
  2011-03-17
Hope For Children Suffering From Hyperinsulinism
  • University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus...
  2011-03-16
New Device Holds Promise Of Making Blood Glucose Testing Easier For Patients With Diabetes
  • People with diabetes could be helped by a new type of self-monitoring blood glucose sensor being developed by Arizona State University engineers and clinicians at Mayo Clinic in Arizona. More than 23 million people in the United States have diabetes. The disease is the fifth leading cause of death in the United States...
  2011-03-16
Insulin-Releasing Switch Discovered
  • Johns Hopkins researchers believe they have uncovered the molecular switch for the secretion of insulin - the hormone that regulates blood sugar - providing for the first time an explanation of this process...
  2011-03-16
Qatar Foundation And WCMC-Q Host International Symposium On Diabetes, Obesity, And The Metabolic Syndrome In Doha
  • Scientists, physicians, and other health care practitioners are gathering in Doha to present and share the latest scientific research on the causes and treatment of diabetes, obesity and the metabolic syndrome at the XVII International DALM Symposium hosted by Qatar Foundation and Weill Cornell Medical College in Qatar and the Giovanni Lorenzini Medical Foundation in Milan, Ita...
  2011-03-15
Newer Doesn't Mean Better When It Comes To Type 2 Diabetes Drugs
  • An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control the chronic disease, new Johns Hopkins research suggests...
  2011-03-15
"Tried And True" Diabetes Drug Still The Best After 15 Years
  • Type 2 diabetes can often be a difficult ailment to treat and new solutions are being put on the market on a regular basis. However, metformin, which has been around for over 15 years and approved by the FDA in 1995, still seems to be the best in class and has fewer side effects and is cheaper than new innovative medicines. Wendy L. Bennett, M.D., M.P.H...
  2011-03-15
Study Seeks To Halt Progression Of Diabetic Nephropathy
  • Researchers at Georgia Health Sciences University are studying whether inhibiting an enzyme that reduces levels of a protective metabolite could halt the progression of diabetic nephropathy, or kidney disease resulting from diabetes. With a four year, $308,000 grant from the American Heart Association, Dr...
  2011-03-15
Does Treating Periodontitis Improve Diabetes Control?
  • The Stony Brook University School of Dental Medicine is leading a multicenter national clinical trial to evaluate whether treatment of chronic periodontitis will help improve diabetes control. Sponsored by the National Institutes of Health (NIH), the Diabetes and Periodontal Therapy Trial (DPTT) monitors blood sugar levels of those with Type 2 diabetes after periodontal therapy...
  2011-03-15
Exenatide Once Monthly Showed Positive Results In Phase 2 Study
  • Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes...
  2011-03-14
Expanded Research Confirms Freedom Meditech Technology Accurately Monitors Glucose Non-Invasively In The Eye With Light
  • People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future get the same results quickly and non-invasively by safely shining a light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and Technology...
  2011-03-13
Tolerx And GlaxoSmithKline Announce Phase 3 Defend-1 Study Of Otelixizumab In Type 1 Diabetes Did Not Meet Its Primary Endpoint
  • Tolerx, Inc. and GlaxoSmithKline (GSK) announced that the Phase 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide at month 12 in patients with new-onset autoimmune type 1 diabetes...
  2011-03-12
FDA Accepts New Drug Application For Investigational Compound Dapagliflozin For The Treatment Of Type 2 Diabetes
  • Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus...
  2011-03-10
New Ultra-Long-Acting Insulin Improves Glucose Control Even When Injected Just Three Times A Week Instead Of Daily
  • A study assessing a new longer-acting form of insulin-degludec- has shown that when given once daily it is as effective at controlling blood sugar as existing insulin glargine injections but with lower rates of hypoglycaemia...
  2011-03-09
Hundreds Of Diabetes Advocates Arrive In Washington, DC To Urge Congress To Stop Diabetes(R)
  • More than 200 volunteer advocates from the American Diabetes Association will meet with their Members of Congress this week, to urge them to support federal funding for diabetes research and prevention programs at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC)...
  2011-03-09
TrialNet Study Seeks Answers To Type 1 Diabetes Questions
  • Individuals at risk for type 1 diabetes can help physicians at Riley Hospital for Children learn more about this life-long disease. Riley Hospital is one of 18 clinical centers in the United States and seven other countries seeking more information on how type 1 diabetes develops in at-risk individuals...
  2011-03-08
Physician's Empathy Directly Associated With Positive Clinical Outcomes In Diabetic Patients
  • It has been thought that the quality of the physician-patient relationship is integral to positive outcomes but until now, data to confirm such beliefs has been hard to find...
  2011-03-08
Ending Diabetes, Supporting Healthy Living And Encouraging Lifestyle Changes For A Better Quality Of Life
  • In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center (BMC) today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes (END Diabetes) Program...
  2011-03-07
Positive Results From Phase 2 Study Of Atrasentan For Treatment Of Diabetic Kidney Disease
  • Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology...
  2011-03-05
Onglyza Becomes The First DPP4 Inhibitor Available For Use In Europe In Type 2 Diabetes Patients With Moderate Or Severe Renal Impairment
  • AstraZeneca and Bristol-Myers Squibb Company announced that the European Commission has approved a label update for ONGLYZA® (saxagliptin) in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose...
  2011-03-05
Non Communicable Diseases Hit The World's Poorest People
  • Non-communicable Diseases (NCDs) are responsible for 8 million deaths in the world's poorest billion. NCDs - cancer, cardiovascular disease, chronic respiratory disease and diabetes - are no longer diseases of the wealthy. These were among some of the key messages coming out of this week's event co -organised by the NCD Alliance1 and Partners in Health, running from March 2-3 in Boston, MA...
  2011-03-03
New Home Blood Pressure Check Created For Diabetics
  • Many people get stressed when they visit the doctor, leading to blood pressure readings higher than normal. It's called "White Coat Syndrome." And since two-thirds of diabetics suffer from high blood pressure, getting accurate readings is crucial to getting proper care for them. Jenna L...
  2011-03-03
Improving The Diagnosis, Classification And Coding Of Diabetes, UK
  • A new report, launched by the Royal College of General Practitioners and NHS Diabetes, aims to improve the diagnosis, classification and coding of diabetes. It provides advice and support to all clinicians involved in this often complex diagnostic challenge as well as providing free, downloadable practice audit tools to aid accurate diagnosis...
  2011-03-02
Omni Bio Pharmaceutical Intends To Expand Type 1 Diabetes Trial To 50 Patients
  • Omni Bio Pharmaceutical, Inc. ("Omni Bio"), an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50...
  2011-03-01
Obesity And Diabetes May Be A Downside Of Human Evolution
  • New research in the FASEB Journal suggests that a gene called CMAH has been lost during the course of recent evolution, and may lead to an increased risk of Type 2 diabetes in humans As if the recent prediction that half of all Americans will have diabetes or pre-diabetes by the year 2020 isn't alarming enough, a new genetic discovery published online in the FASEB Journal pr...
  2011-02-28
Simple Home Urine Test Measures Insulin Production In Diabetes Patients
  • A single home urine test which can be sent by post may replace multiple blood tests in hospital - the test measures whether or how much insulin is being produced by individuals with diabetes Type 1 and Type 2. The test kit was developed by Professor Andrew Hattersley and team from the The Peninsula College of Medicine and Dentistry, Exeter, England...
  2011-02-26
AHRQ News And Numbers: Spending For Prescriptions To Control Cholesterol And Diabetes Exceed $52 Billion
  • Insurers and consumers spent $52.2 billion on prescription drugs in 2008 for outpatient treatment of metabolic conditions such as diabetes and elevated cholesterol, according to the latest News and Numbers from the Agency for Healthcare Research and Quality (AHRQ). Metabolic medicines were the class of drugs with the highest level of spending in 2008...
  2011-02-25
Diabetic Wound Healing Improved By Human Umbilical Cord Blood Cells
  • Transplanting human umbilical cord blood-derived endothelial progenitor cells (EPCs) has been found to "significantly accelerate" wound closure in diabetic mouse models, said a team of Korean researchers publishing in the current issue of Cell Transplantation (19:12), now freely available on-line here. According to the study's corresponding author, Dr...
  2011-02-24
T-fal® Joins With American Diabetes Association's® Movement To Stop Diabetes®
  • T-fal, the leading manufacturer of non-stick cookware and small kitchen appliances, announced that it has joined the American Diabetes Association's Stop Diabetes® movement for 2011. The company has donated $100,000 in support of the American Diabetes Association and its effort to communicate the benefits of eating properly to effectively prevent and control type 2 diabetes...
  2011-02-23
The Frontiers Of Islet Cell Transplantation
  • Two studies published in the current issue of Cell Transplantation (19:12) investigate frontiers of islet cell transplantation for treating diabetes. Researchers in Milan, Italy re-examine the role of bone marrow stem cells in diabetic therapy and islet cell regeneration and Canadian researchers offer improved strategies for optimizing pancreatic islet culture in vitro...
  2011-02-21
NBA Joins American Diabetes Association And Sanofi-Aventis U.S. To Support New Dribble To Stop Diabetes Awareness Campaign
  • The National Basketball Association (NBA), the Women's National Basketball Association (WNBA) and the NBA Development League, in collaboration with the American Diabetes Association and sanofi-aventis U.S...
  2011-02-18
Statement By John Griffin, Chair Of The Board Of The American Diabetes Association Regarding Proposed Cuts In House FY 2011 Funding Bill
  • The American Diabetes Association is alarmed about the proposed cuts to federal health programs included in H.R.1, the Full-Year Continuing Resolution, 2011, and the threat that these cuts pose in the fight to stop diabetes. The Association supports fiscal responsibility, but not at the expense of America's health and well-being...
  2011-02-18
Brain Insulin Plays Critical Role In The Development Of Diabetes And Obesity
  • Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans. The research is published this month in the journal Cell Metabolism...
  2011-02-17
American College Of Physicians Issues Guideline For Use Of Intensive Insulin Therapy For The Management Of Glycemic Control In Hospitalized Patients
  • Poorly controlled hyperglycemia is associated with increased illness, death, and worsening health outcomes in hospitalized patients. While most doctors make efforts to prevent and control hyperglycemia in hospital settings, the use of intensive insulin therapy and optimal blood glucose range to target in hospitalized patients has been uncertain...
  2011-02-16
Joslin's Latino Diabetes Initiative Unveils Enhanced Website
  • Latinos are twice as likely to develop diabetes as Caucasians, and half the Latinos born in the United States in this century are expected to get the disease...
  2011-02-15
People At Risk Of Diabetes Offer Clues Toward Novel Drugs
  • Once people develop type 2 diabetes, high blood glucose levels alter their metabolism so much that it becomes difficult to sift through all the clues to find what might enable the disease. "To identify factors that play a primary role in disease susceptibility, we want to investigate people before they get to that point," says Mary-Elizabeth Patti, M.D. of Joslin Diabetes Center...
  2011-02-15
Clinical Trial Will Test Whether Surgery Is The Best Option For Type 2 Diabetes, Even For Patients Who Aren't Obese
  • A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese...
  2011-02-11
Quality Varies In Social Networking Websites For Diabetics
  • Nearly one-half of U.S. adults who use the Internet participate in social networks. While these increasingly include health-focused networks, not much is known about their quality and safety...
  2011-02-10
New Diabetes Statistics Further Highlight The Urgent Need For Prevention And Early Detection
  • New data released last week from the Centers for Disease Control and Prevention (CDC) paint an urgent picture of the state of diabetes, estimating that nearly 26 million children and adults in the United States are now living with diabetes...
  2011-02-09
Evolution Led To Genetic Variation That May Affect Diabetes, Stanford Scientist Says
  • The root causes of complex diseases such as type-2 diabetes and obesity have been difficult to identify because the diseases are, well, complex. They occur at the dicey biological intersection of genes and environment, and, because they arose in our relatively recent past, it's not easy to simply compare DNA sequences from "then" and "now" to pinpoint likely genetic culprits...
  2011-02-08
Kaiser Permanente Southern California Awarded More Than $3 Million From CDC For Research In Childhood Diabetes
  • The Kaiser Permanente Southern California Department of Research & Evaluation has been awarded more than $3 million from the Centers for Disease Control and Prevention to continue the SEARCH for Diabetes in Youth Study for an additional five years to 2015...
  2011-02-07
Diabetes Management - A New Journal Addressing The Management Issues Of A Complex Disease
  • Future Medicine Ltd has announced the launch of Diabetes Management - a new bimonthly title presenting findings, analyses and commentaries on the battle with Type 1 and Type 2 diabetes...
  2011-02-07
Regenerative Medicine Research In Type 1 Diabetes Funded By Lilly And JDRF Partnership
  • Eli Lilly and Company (NYSE: LLY) and the Juvenile Diabetes Research Foundation (JDRF) have announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease...
  2011-02-07
Tethys Bioscience, Inc. Selects RemedyMD Enterprise Registry Solutions To Further Expand Adoption Of PreDx™ Diabetes Risk Score (DRS) Offering
  • RemedyMD®, Inc. - "Tethys is executing an aggressive program to drive market uptake of the PreDx Diabetes Risk Score for the identification of patients at high risk of developing type 2 diabetes," explains Mickey S. Urdea, PhD, chairman and chief executive officer of Tethys. "Since early 2009, more than 15,000 PreDx tests have been ordered in the U.S...
  2011-02-03
Anna Katherine Tollett, From Louisiana, Wins American Diabetes Association's National Video Contest
  • The American Diabetes Association is pleased to announce that Anna Katherine Tollett, from Louisiana, is the grand-prize winner of the Share Your Vision to Stop Diabetes® video contest. The video received the most votes during the two-week national contest, which was sponsored by VSP® Vision Care...
  2011-02-02
Online Survey Launched To Help People Talk Diabetes
  • People with diabetes across the UK are being asked to open up and take part in a new online survey to help leading health charity Diabetes UK find out whether talking about diabetes has ever had an impact on how people manage their condition. Many people with diabetes may only have contact with a healthcare professional for a total of a few hours per year...
  2011-02-02
Loyola's Diabetes Clinic Offers One-Visit, Comprehensive Care
  • More than 23 million people in the United States have diabetes, according to the American Diabetes Association. Each year more than a million more cases will be diagnosed. Untreated or poorly managed diabetes can cause severe health complications such as kidney failure, blindness, heart disease, stroke and nerve damage...
  2011-02-01
European Diabetes Research Network Receives 6 Million Euros
  • The Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, is one of 13 academic institutions and businesses across Europe to form a 6m euro research and analysis network, funded by the EU for a five-year period, which is designed to investigate the possible role of virus infection in the cause of type 1 diabetes...
  2011-01-31
Reviews In Neurological Diseases Publishes A Study That Demonstrates How Metanx(R) Improves Numbness In Diabetic Neuropathy Patients
  • PamLab L.L.C., developer and marketer of Metanx®, announced that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases...
  2011-01-28
Study: Diabetes Affects Patients' Well-Being And Also Impacts Spouses
  • Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University...
  2011-01-28
26 Million Have Diabetes And 79 Million Prediabetes In America
  • Over one third of all adults in the USA have pre-diabetes, a total of 79 million people, while the number estimated to have diabetes has risen to 26 million today, compared to 23.6 million in 2008, according to a new report issued by the CDC (Centers for Disease Control and Prevention). Prediabetes is when blood sugar levels are too high, but not enough for a diagnosis of diabetes to be reached...
  2011-01-27
Researchers Uncover Potential 'Cure' For Type 1 Diabetes
  • Type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone, new findings by UT Southwestern Medical Center researchers suggest. These findings in mice show that insulin becomes completely superfluous and its absence does not cause diabetes or any other abnormality when the actions of glucagon are suppressed...
  2011-01-27
American Diabetes Association Announces 2010 Diabetes Year-In-Review
  • The American Diabetes Association released its diabetes year-in-review for 2010. The complete list, which highlights focusing on diabetes achievements by the numbers, can be found here...
  2011-01-26
Diamyd Medical: Diamyd Expects To Begin Reporting Phase III Results In Late Spring 2011
  • Diamyd Medical's President and CEO Elisabeth Lindner states in the CEO comments in today's quarterly report that the Company expects to begin reporting the results from the European Phase III trial in type 1 diabetes as planned in late spring 2011...
  2011-01-26
Why Do Some Diabetics Escape Complications?
  • Much research has been carried out on why diabetics develop complications. Now researchers are asking the question the other way around. They want to know why some diabetic patients do not develop complications. What is it that protects them? The PROLONG study could provide the answer...
  2011-01-22
Prevention Launches Free "Outsmart Diabetes" Content Area
  • Today, Prevention-the #1 healthy lifestyle brand in the world-launches Outsmart Diabetes: a personalized, feature-rich, free content area consisting of all Prevention's superior diabetes coverage here. Outsmart Diabetes joins Prevention's overall diabetes platform, which includes books, DVD's, special interest publications and bookazines...
  2011-01-21
MannKind Corporation Receives Complete Response Letter From The FDA For AFREZZA(R)
  • MannKind Corporation (Nasdaq: MNKD) announced that it has received a complete response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA® (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes for the control of hyperglycemia...
  2011-01-21
Novo Nordisk's New Pen For Children - NovoPen Echo(R) - Wins GOOD DESIGN(TM) Award
  • A 2010 GOOD DESIGN(TM) Award[1] has been awarded to Novo Nordisk for NovoPen Echo(R), the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives...
  2011-01-21
American Diabetes Association Announces Tamara Darsow, PhD, As New Vice President, Research Programs
  • The American Diabetes Association announced that Tamara "Mara" Darsow, PhD, has been named the Association's Vice President of Research Programs. As a part of the Association's Scientific & Medical Division leadership team, Darsow will oversee the research grants programs and research committees, while also providing scientific support for the Association's Research Foundation...
  2011-01-20
Statement On The Patient Protection And Affordable Care Act
  • Last year, the passage of the Patient Protection and Affordable Care Act was a historic moment for people with diabetes and for those at risk for diabetes. That's because of provisions in the law that provide for quality, affordable diabetes care and diabetes prevention. But it wasn't without controversy and struggle...
  2011-01-20
New OneTouch(R) UltraMini(R) Blood Glucose Meter With SmartCode25™
  • For many Canadians living with diabetes, regular blood glucose monitoring, as recommended by their healthcare professional, is a key part of their daily diabetes management and can help prevent or delay serious complications. However, the majority of people living with diabetes sometimes experience uncertainty between their blood glucose readings and how they feel...
  2011-01-18
Taking More Steps Every Day Can Help Ward Off Diabetes
  • Simply taking more steps every day not only helps ward off obesity but also reduces the risk of diabetes, finds a study published on bmj.com today...
  2011-01-14
Why Coffee Protects Against Diabetes
  • Coffee, that morning elixir, may give us an early jump-start to the day, but numerous studies have shown that it also may be protective against type 2 diabetes. Yet no one has really understood why. Now, researchers at UCLA have discovered a possible molecular mechanism behind coffee's protective effect...
  2011-01-14
The Type 2 Talk™ Public Health Initiative Launches To Motivate People To Actively Manage Their Type 2 Diabetes
  • The American Association of Clinical Endocrinologists (AACE) and its educational arm - the American College of Endocrinology (ACE) - in partnership with Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN), announced a new public health initiative for people with type 2 diabetes mellitus called The Type 2 Talk: Changing the Type 2 Diabetes Conversation™...
  2011-01-13
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(R) For Type 2 Diabetes
  • Merck announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States...
  2011-01-13
Boehringer Ingelheim And Eli Lilly And Company Announce Strategic Alliance To Bring New Diabetes Treatments To Patients Worldwide
  • Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development...
  2011-01-12
Sangamo BioSciences Announces Completion Of Enrollment Of Phase 2b Clinical Trial In Diabetic Neuropathy
  • Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011...
  2011-01-12
German And U.S. Pharma Giants Join To Battle Diabetes Epidemic
  • International pharmaceutical companies Eli Lilly and Boehringer Ingelheim will announce today to investors, an alliance that will forge the way to a massive expansion in diabetes research, prevention and treatment...
  2011-01-11
Sharing Their Vision To Stop Diabetes(R)
  • Now that movie award season is in full swing, the American Diabetes Association is inviting the public to become a film critic. Between now and January 24, the public is invited to vote for the three finalists, which includes the grand-prize winner in the Share Your Vision to Stop Diabetes® video contest. The video contest is sponsored by VSP® Vision Care and the public can vote here...
  2011-01-11
KOMBIGLYZE™ XR Tablets, A New Treatment For Type 2 Diabetes Mellitus In Adults, Now Available In U.S. Pharmacies
  • Bristol-Myers Squibb Company (NYSE: BMY), and AstraZeneca (NYSE: AZN) today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States...
  2011-01-10
American Diabetes Association Announces Legislative Priorities
  • The American Diabetes Association®, the nation's leading voluntary health organization in the fight to Stop Diabetes®, is pleased to announce its legislative priorities for the first session of the 112th Congress. Each year, the Association identifies the leading legislative priorities and key policy goals as part of the effort to Stop Diabetes®...
  2011-01-10
The Number Of U.S. Adults Treated For Diabetes More Than Doubled Between 1996 And 2007
  • Approximately 19 million U.S. adults reported receiving treatment for diabetes in 2007, more than double the 9 million who said they received care in 1996, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. AHRQ also found that between 1996 and 2007: -- The number of people age 65 and older treated for diabetes increased from 4...
  2011-01-08
The Number Of U.S. Adults Treated For Diabetes More Than Doubled Between 1996 And 2007
  • Approximately 19 million U.S. adults reported receiving treatment for diabetes in 2007, more than double the 9 million who said they received care in 1996, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. AHRQ also found that between 1996 and 2007: The number of people age 65 and older treated for diabetes increased from 4...
  2011-01-07
Baylor Researchers Take Step Forward In Diabetes Study
  • Researchers at Baylor All Saints Medical Center are studying a solution they believe will improve the quantity and quality of isolated human pancreatic islet cells. The harvested cells can then be transplanted into the livers of patients with Type 1 diabetes, enabling them to produce their own insulin...
  2011-01-07
Routine Blood Test May Identify People With Pre-Diabetes, Cutting Later Treatment Costs
  • A simpler form of testing individuals with risk factors for diabetes could improve diabetes prevention efforts by substantially increasing the number of individuals who complete testing and learn whether or not they are likely to develop diabetes Approximately 60 million Americans, one-third of the adult population, are pre-diabetic...
  2011-01-07
Nonin Medical Announces Microsoft® HealthVault™ Certification Of World's First Continua™-Certified, Bluetooth® Wireless Fingertip
  • Nonin Medical, Inc., the inventor of fingertip pulse oximetry and a leader in noninvasive physiological monitoring, announced that the Onyx® II Model 9560 Continua™-Certified, Bluetooth® wireless fingertip pulse oximeter has received Microsoft® HealthVault™ certification...
  2011-01-07
Santarus And Depomed Announce Availability Of GLUMETZA 500 Mg Tablets
  • Santarus, Inc. (NASDAQ: SNTS) and Depomed, Inc. (NASDAQ: DEPO) announced that supply of GLUMETZA® 500 mg (metformin HCl extended release tablets) to wholesalers and retailers has resumed. GLUMETZA is a once-daily, extended release formulation of metformin and is approved for use in adults with type 2 diabetes mellitus. GLUMETZA 500 mg and GLUMETZA 1000 mg are promoted in the U.S...
  2011-01-06
'Diabetes' Is Fifth Disability Intensive Course Introduced To College Of Direct Support (CDS) Curriculum
  • The College of Direct Support (CDS), an internet-based college for Direct Support Professionals (DSPs) and managed in partnership by Elsevier I MC Strategies and the University of Minnesota's Research and Training Center, has introduced its newest Disability Intensive Course (DIC) into the CDS Curriculum Diabetes...
  2011-01-05
Revised Standards Of Care Call For Changing How Gestational Diabetes Should Be Diagnosed
  • The American Diabetes Association is recommending changes in the way pregnant women are tested for gestational diabetes, which will likely result in a doubling of the number of women diagnosed, but should also reduce the health risks to mother and baby...
  2011-01-04
Diabetes Forecast Consumer Guide 2011: The Latest Tools For A Healthy Diabetes Lifestyle
  • Diabetes Forecast, the consumer magazine of the American Diabetes Association, has published its annual Consumer Guide in its January issue. The number of products on the market can be overwhelming, so Diabetes Forecast seeks to help people with diabetes select the ones that best meet their needs...
  2011-01-04
Team-based Approach To Patient Care Shows Success In Fight Against Depression With Diabetes, Heart Disease
  • Many people in the U.S. have multiple common chronic diseases such as diabetes and heart disease, which complicates health care needs. When depression coexists with diabetes, heart disease, or both, health outcomes are often less favorable...
  2010-12-30
New Clues Uncover How "Starvation Hormone" Works
  • New findings by UT Southwestern Medical Center researchers may solve a 17-year-old mystery about how the so-called "starvation hormone" affects multiple biological systems, including preventing insulin sensitivity and promoting cell survival...
  2010-12-28
Nursing Case Management Affects Outcomes Of High-Risk Patients With Diabetes
  • Patients with diabetes who follow a self-care regimen generally have success in controlling their disease...
  2010-12-27
Iluvien For Diabetic Macular Edema Turned Down By FDA
  • Investigational drug Iluvien (fluocinolone acetonide intravitreal insert) for the treatment of diabetic macular edema cannot be approved in its present form, the FDA (Food and Drug Administration) wrote in its Complete Response Letter (CRL). Illuven is the result of a collaboration between pSdivida Corp. and Alimera Sciences Inc...
  2010-12-24
Researchers Uncover Cellular Mechanism Responsible For Chronic Inflammation, Type 2 Diabetes
  • Researchers from Boston University School of Medicine (BUSM) have demonstrated that certain T cells require input from monocytes in order to maintain their pro-inflammatory response in people with type 2 diabetes (T2D). The study also showed, for the first time, how a loss in homeostasis in this group of T cells most likely promotes chronic inflammation associated with T2D...
  2010-12-23
Study Identifies Cells That Give Rise To Brown Fat
  • In some adults, the white fat cells that we all stockpile so readily are supplemented by a very different form of fat brown fat cells, which can offer the neat trick of burning energy rather than storing it...
  2010-12-22
Diabetes Risk May Be Reduced By Component In Common Dairy Foods
  • Scientists at the Harvard School of Public Health (HSPH) and collaborators from other institutions have identified a natural substance in dairy fat that may substantially reduce the risk of type 2 diabetes. The compound, trans-palmitoleic acid, is a fatty acid found in milk, cheese, yogurt, and butter. It is not produced by the body and so only comes from the diet...
  2010-12-21
Almonds May Help Reduce Risk Of Type 2 Diabetes And Heart Disease
  • With nearly 16 million Americans living today with prediabetes, a condition that is the precursor to type 2 diabetes, and half of all Americans expected to have either prediabetes or type 2 diabetes by the year 2020, nutritional approaches to maintaining healthy blood sugar levels are essential...
  2010-12-20
Nursing Case Management Affects Outcomes Of High-Risk Patients With Diabetes
  • Patients with diabetes who follow a self-care regimen generally have success in controlling their disease...
  2010-12-17
AHRQ News And Numbers: One In 16 Women Hospitalized For Childbirth Has Diabetes
  • More than a quarter million women who gave birth in U.S. hospitals in 2008 had pre-existing diabetes or developed it during their pregnancy - a condition called gestational diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This equals 6.4 percent of the 4.2 million women who gave birth in that year...
  2010-12-16
Diabetes Care Improved By Disease-Management Programs
  • Disease-management programs, which may include patient education, psychological intervention, dietary education, self-monitoring and telemedicine, can improve diabetes care, states an article in CMAJ (Canadian Medical Association Journal). The study, by French researchers, included 41 randomized controlled trials published between 1990 and 2009 with a total of 7013 patients...
  2010-12-15
Research Presented At American Society For Cell Biology's 50th Annual Meeting: 'In Vivo' And 'In Vitro' Studies
  • Small details between "in vivo" and "in vitro" studies make for big differences in understanding diabetes and other secretory dysfunctions Exocytosis, the fundamental process by which cells secrete hormones such as insulin and other useful biological substances, is regulated far differently in life than in laboratory tissue cultures and explanted organs, according to researc...
  2010-12-15
Medtronic Launches CareLink Pro 3.0, The First Diabetes Management Software To Offer Advanced Decision Support
  • Medtronic, Inc. announced the Food and Drug Administration (FDA) approval and the market launch of CareLink® Pro 3.0 Therapy Management Software, the first software program to offer advanced decision support to healthcare professionals managing diabetes...
  2010-12-14
For Men With Type 1 Diabetes It May Be Possible To 'Grow Your Own Transplant'
  • Men with type 1 diabetes may be able to grow their own insulin-producing cells from their testicular tissue, say Georgetown University Medical Center (GUMC) researchers who presented their findings at the American Society of Cell Biology 50th annual meeting in Philadelphia...
  2010-12-13
Sperm Stem Cells Turned Into Insulin-Producing Cells
  • Using sperm stem cells to make pancreatic beta insulin-producing cells could one day form the basis of a safe treatment for type 1 diabetes in men with the disease, and there is no reason why a similar treatment based on egg stem cells should not be feasible for women with the disease, scientists told a conference in the US on Sunday. Dr G...
  2010-12-13
Johns Hopkins Researchers Uncover Potential Inroad To Diabetes Treatment
  • A myriad of inputs that report on a body's health bombard pancreatic beta cells continuously, and these cells must consider all signals and "decide" when and how much insulin to release to maintain balance in blood sugar, for example...
  2010-12-13
American Diabetes Association Applauds Two-Year Re-Authorization Of Special Diabetes Program
  • The American Diabetes Association®, the nation's leading voluntary health organization in the fight to Stop Diabetes®, praises Congress for reauthorizing the Special Diabetes Program...
  2010-12-13
New Software Accurately Predicts Key Information On Nasal Insulin Treatment
  • A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes...
  2010-12-11
JDRF Applauds Congress For Passage Of $300 Million For Type 1 Diabetes Research
  • "Today Congress passed a multi-year renewal of the Special Diabetes Program (SDP), ensuring that studies on promising diabetes treatments and avenues toward a cure continue uninterrupted. As the father of a son living with type 1 diabetes, and as CEO of JDRF, one of the leading advocates for the renewal of this program, I applaud the U.S...
  2010-12-10
Exercise Can Help Tame Type 2 Diabetes, Say New Guidelines
  • New guidelines on exercise for people with diabetes are likely to open some eyes and, for those who follow them, help prevent or manage diabetes, improve overall health and boost quality of life. A panel of nine experts developed the recommendations, published this month in Medicine & Science in Sports & Exercise®, the official journal of the American College of Sports Medicine (ACSM)...
  2010-12-10
On... Off... On... Off... The Circuitry Of Insulin-Releasing Cells
  • A myriad of inputs can indicate a body's health bombard pancreatic beta cells continuously, and these cells must consider all signals and "decide" when and how much insulin to release to maintain balance in blood sugar, for example...
  2010-12-10
Access Pharmaceuticals Signs Agreement With Major Global Pharmaceutical Company For Its CobOral™ Oral Insulin Formulation
  • ACCESS PHARMACEUTICALS, INC...
  2010-12-09
Albert Einstein College Of Medicine To Study Impact Of Resveratrol On Prediabetes
  • Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded $600,000 from the American Diabetes Association (ADA) to study the effect of resveratrol, a chemical compound most notably found in red wine and grapes, on impaired glucose tolerance (IGT) in older adults...
  2010-12-09
Limiting Salt Lowers Blood Pressure And Health Risks In Diabetes
  • For patients living with diabetes, reducing the amount of salt in their daily diet is key to warding off serious threats to their health, a new review of studies finds. In the Cochrane review, the authors evaluated 13 studies with 254 adults who had either type 1 or type 2 diabetes...
  2010-12-09
Valeritas Receives FDA 510(k) Clearance For The V-Go™ Disposable Insulin Delivery Device
  • Valeritas, Inc...
  2010-12-09
Combining Exenatide With Insulin May Be 'Best Result Ever' For Diabetes Patients
  • A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss...
  2010-12-08
Glucose-Responsive Insulin Advances Toward Clinical Development
  • Pharmaceutical company, Merck & Co., Inc. has announced that it will acquire SmartCells, Inc., a private biotech developing a glucose-responsive insulin whose proof-of-concept preclinical trials were partially funded by the Juvenile Diabetes Research Foundation (JDRF)...
  2010-12-07
New Study Calls For Greater Awareness Of Food Supply For Children With Diabetes
  • Managing diabetes in a child requires a careful balance of insulin, diet, and exercise. Buying essential medical supplies, such as needles and testing strips, adds a financial burden to families...
  2010-12-03
Diabetic Brains Suffer From Lack Of Cholesterol
  • Our brains are packed with cholesterol, almost all of which has to be produced within the brain itself, where it is critical for normal brain functions. Now, a new study in the December Cell Metabolism, a Cell Press publication, reveals how that critical cholesterol synthesis in the brain is derailed in mice with diabetes...
  2010-12-02
San Francisco Health Plan's Outreach Program Achieves Significant Results In Diabetes Care
  • San Francisco Health Plan (SFHP), the city's community health plan, announced today that clinics participating in the chronic care program, "Strength in Numbers," saw significant improvements in diabetes care. SFHP developed Strength in Numbers in partnership with Healthy San Francisco, the universal health access program...
  2010-12-01